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Syringomyelia is an important condition in which a cystic cavity forms within the spinal
cord. This leads to significant delayed neurological deterioration, which may be manifested
as weakness, numbness or pain. The patho-physiology and mechanism of syrinx formation
remains unclear. Human autopsy findings have demonstrated a prominent accumulation of
macrophages in relation to the syrirx. Similar observations have also been made in a
previously established rat model of syringomyelia. Little is known about the origin and
precise functions of these cells.
Purpose:
The study was aimed at identifying the origin of macrophages in an experimental model of
rat syringomyelia. The pattern and time course of macrophagic infiltration was also
evaluated.
Method:
Syrinx formation was induced by intra-parenchymal injections of kaolin within the cervical
spinal cords of 30 DA rat @T7.1) radiation bone marrow chimeras reconstituted with
bone marrow from FtT7.2 congeneic donors. The distribution of macrophages was
evaluated at survival times of 3 days, I week and 4 weeks. Immunostaining of fresh frozen
spinal cord tissue was performed using specific antibodies against rat macrophage EDI
1
antigen and RT7.2 allele of CD45. This allowed donor-derived haematogenous
macrophages to be distinguished from native cells.
Results:
Central canal dilatation was seen from I week. This was associated with extensive
accumulation of EDl* macrophages within the spinal cord parenchyma. A large influx of
bone marrow derived (EDl*, RT7.2.) macrophages was observed. However, a
considerable proportion of resident microglia (RT7.2) also upregulated EDl. These
activated microglia demonstrated distinct morphological features.
Conclusions:
Largenumbers of macrophages were recruited from the bone marrow in kaolin-induced
rat syringomyelia. However, a significant number of resident microglia upregulated their








,,It appears doubtfut that syringomyelia can be regarded as a single entity eitherfrom the
point of clinical presentation, from the view point of pathogenesis, or, most importantly,
from the standpoint of rational therapy." 
85
Syringomyelia is a progressive myelopathy characterised pathologically by cavitation of
the central spinal cord. 'ar As a clinical entity, the varied and diverse symptomatology has
posed significant diagnostic challenges. As a pathological entþ, it is well recognised as a
heterogeneous disease process of which the pathogenesis remains poorly understood.
The current work begins with a review of the literature on syringomyelia. Particular








Although Schlesinger 3a8 considered syringomyelia to be one of the commonest spinal cord





The prevalence and incidence figures are difficult to establish accurately. In a 1966 survey
of neurological disease in an English city, Brewis et alas found a prevalence rate of
8.4/100,000 persons. Later estimates yielded similar figures."t''e2 Overall incidence figures
have never been assessed. However, with increasing use of CT and MRI scanning,
syringomyelia is increasingly diagnosed, often in asymptomatic patients-20'tto'316
1.3 Clinical features
"syringo-myelia, inwhich the symptoms are often numerous, so to speak, unforseen, so
varied is the seat of the lesions which constitute that affection, is often attended by
phenomena, which are more or less analogous to those occurring in tabes: these consist
of rrophic derangements, sensory disorders, pains, and at times the loss of the Imee
. t ,1252
JerK.
Syringomyelia usually begins during the second and third decades of
[fe.44,r0r,25r'25eAffected patients may present with variable symptoms and signs, which were
aptly highlighted by the neurologist, Marie late in the 18th century. Hence, it is not











The classical manifestations of syringomyelia correspond to a high cervical cord syndrome
and may vary depending on the extent of the syrinx and its associated abnormalities. 
3nt
However, the most prominent feature at presentation appears to be motor impairment of
the upper limbs. 
r4'25r'388Padovani et al presented a series of 29 patients with both
'hindbrain related' and 'non-hindbrain related' syringomyelia, in which all the patients
demonstrated motor weakness. 
303 Typically, a patient may initially notice the slow onset
of wasting and weakness of one hand. 1a Wasting of the first dorsal interosseous muscle
may occur relatively early in the course of the disease.t00'438 Alternatively, there may be
loss of sensation over one hand and forearm leading to injuries, especially burns, which are
often unnoticed. 
on''*t The majority of patients present with unilateral symptoms. 'o' In
other patients, the symptoms may also be bilateral but asymmetric, 
aa'tor
Headaches or pain in the cervical area also occur commonly, particularly in patients with
Chiari malformations. Certainly, this was the predominant complaint (65%) in a series of
patients with Chiari malformation-related syringomyelia.222^similar finding was reported
by Logue and Edwards. 'ot Williams noted that the majority of these patients described an
occipital "hindbrain related headache" which was exacerbated by straining activities.a3E






Patients may also experience pain in the trunk or limbs. 
t4'223'241'2sr'25e'303'347'388'a3E'aa3'1¡tt
typically has an aching or burning quality and is lateralised to the face, neck, limbs or trunk
within the area of pain and temperature impairment. 'n' Other patients may experience
radicular or localised spinal pains. 
lo'307 Straining manoeuvres such as coughing or
sneezing can result in an electric shockJike, tearing or ripping pain which is often
confined to a zone of the body but not usually to one dermatome.24L'438
Examination is likely to demonstrate distal weakness, wasting and hypotonia in at least
one upper limb. 
oa'"s More proximal muscle groups in the lower neck, shoulders and
upper arms may also be affected. 
3al Fasiculations are seen in the affected muscle groups
although these may be subtle. 
aa'2et Tendon reflexes in the affected limb are often
diminished or lost earþ in the course of the disease. 
44'l0r The lower limbs are
characteristically spastic and extensor plantar responses are contmon. "t Interestingly,
Foster and Hudgson found that'stiffiress of the legs' consistent with spastic paraparesis
was the coÍtmonest earþ complaint seen in 42%o of their patients. 
r0l
There is associated loss of pain and temperature sensation in the affected limb. The
distribution typically involves the ulnar side of the hand and forearm, before spreading to
the radial side and onto the neck and chest although the precise dermatomal level often
cannot be defined. 
o'* The preservation of light touch, vibration sense and postural stability
leads to a pattern of "dissociated sensory loss". 
2el'3al 16tt is relatively common although
the classical'capeJike' distribution of sensory loss over the nape of the neck, shoulders
and upper arms is much less common. 
t4'ror'223'4'*'on'When the syrinx extends to involve
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the pons or medulla (syringobulbia), 
3al'376 a characteristic 'onion-skin' pattern of
dissociated sensory loss which converges onto the nose and upper lip occurs.
Another cardinal clinical sign of syringomyelia is high thoracic þphoscoliosis. 
3at Trunk
weakness commonly leads to spinal deformities and is associated with significant disability
ttt In one series, 25lscoliosis was clinically evident in28Yo of cases but could be
radiologically documented in 64Yo of patients at follow up.
Ocular sympathetic paralysis leading to ptosis and small pupils (Horner's syndrome) may
be present. 
tor'223'2et'438' Other ocular signs such as nystagmus may be present inup to 47Yo
ofpatients. tot'223
Less common clinical presentations include episodic dizziness, drop attacks, tongue
weakness, dysarthria, palatal and vocal cord paralysis, tic douloureux, trigeminal
hypalgesia, diplopia, urinary incontinence, Charcot joints, cauda equina syndrome,
Lhermitte's phenomenon and decreased facial sweating. 
Á'tor'zz5'251'34t'347'443 Rarely,
extremely acute presentations with paraplegia, respiratory failure and lateral medullary
compression have also been reported. 
a5t
1.4 Progression of disease
The natural history of untreated syringomyelia is often unpredictable and variable.
224,24r'2st'2e6'341'347 The course is usually protracted over 10 to 15 years but possibly up to
5 o years. 
6s'222'24t'2se'2e I
,|
For many patients, there is a gradual deterioration of symptoms. 
ut'"'In others, the disease
may either be stationary or appear to progress before plateauing. 
ts5'222'2s2'2er Curiousl¡ the
disease process may cease to progress at any time. 
r5s However despite the apparent
stability in some patients, late neurological deterioration may still occur. 
303 Deterioration
of neurological deficits after coughing or sneezing has occasionally been noted by patients'
241,341
While the progression is typically relentless, 
on syringomyelia rarely causes death directly
unless it is associated with syringobulbia. 
ttt
8
1.5 Neuropathology in syringomyelia
Syringomyelia may be associated with tumours, vascular changes, infective processes,
extramedullary compressive lesions and congenital anomalies. 
s4'e4'1s4'1t'''ot However, with
the exception of neoplastic syringomyelia, the histopathological findings are similar
regardless of the associated condition. 
376
1.5.1 DeJinitions
The definition of syringomyelia is important in the neuropathological evaluation of this
condition. Greenfield defined syringomyelia as a "tubular condition of the spinal cord
extending over many segments". 
ttt On the other hand, Barnett and Rewcastle placed less
emphasis on the dimensions of the cavity, defining it as a "cavitation in the spinal cord
which has a wall largely composed of glial tissue". tt Some authors funher distinguish
syringomyelia from'hydromyelia', which is said to involve the dilation of the ependyma-
lined central canal. In the current thesis, such a differentiation is not made.
1. 5. 2 Macroscopic features
Syringomyelia most commonly affects the lower cervical and upper thoracic spinal cord.
44't5s'34r'376 The cavity is usually the largest in the cervical region but rarely involves the
first cervical segment. r55'25e This extends variably into the thoracic segments although the
lumbosacral enlargement is rarely involved. 
155
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When exposed at operation or autopsy, the spinal cord appears swollen (mainly in the
transverse plane) and tense in the affected region. 
44'rs5It may fill the entire spinal canal.
Externally the spinal cord appears otherwise normal and there is usually no leptomeningeal
thickening. tss Typically, the transverse section reveals a cavity containing clear (like CSF)
or yellow fluid with a high protein content. 
t8'rt5'442 Occasionally, the cavity may reach
massive proportions, occupying most of the cross section of the cord. 
ls5Upon release of
the fluid from within the syrinx, the cord becomes flattened most commonly in an anterior-
posterior diameter.
The shape and structure of the cysts are both variable and complex. Instead of a single
cavity, each cyst may consist of several separate cavities which communicate variably with
each other. 2ea In the thoracic cord, the syrinx is often located unilaterally in the posterior
horn. When present bilaterally, the cavities may communicate in a U-shaped manner in the
grey commissure. 
ttt
Syrinxes usually extend over multiple segments of the spinal cord. 
tooThey may extend
rostrally to the pons, midbrain and as far as the centrum semi-ovale. 'oo V/hile the syrinx
may arise in continuity with the fourth ventricle, most commonly the syrinx involves a
dilation of the central canal which is discontinuous with the fourth ventricle.
Approximately 40Yo of these syrinxes demonstrate evidence of rupture paracentrally and
dissection into the parenchymal tissues. 'u'The cavity may reach the pial surface at the tips
of the dorsal horns at any level. r55 Occasionally, the cavity may communicate with the
10
subarachnoid space. 
172In the remaining cases, the cysts are extra-canalicular and may be
found at variable levels distal to the obex. 
26e
1,5.2.1 Neuroanatomical considerations
Consistent with the resultant symptoms, the syrinx often occupies the central gray matter
and frequently extends to involve the posterolateral tracts and the posterior gray
. 44-155-29.cornmrssure. t Thus fibres passing into the spinothalamic tracts may be involved at
the posterior horns or as they cross the midline in the central commissure. Similar patterns
of syrinx formation have been observed in experimental animal models following cisternal
kaolin injection. 
2ae32e'a3t'¡6s has been attributed to the lack of connective tissue in this
region of the spinal cord. 
5'031
The anterior white commissure is also often destroyed by pressure effects or direct midline
extension of the cavity. 
rtsExpansion of the cavitylcavities and associated gliosis lead to
compression of the anterior horns of the grey matter resulting in atrophy of the anterior
horn cells and axonal degeneration. 
ooCompression and degeneration of the long
ascending and descending tracts occur late in the process with involvement of the
pyramidal and spinocerebellar tracts and dorsal columns. 
ltt
1. 5. 2 Microscopic features
The syrinx is typically surrounded by a dense concentric wall up to l-2 mm in thickness.
ttt This usually consists of either fibrillary glial tissue or collagenous tissue although some
parts of the cavity may be lined by ependyma. 
e4'2er'2e2'2e4'3tu The overall histological
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appearances are variable and dependent on the part ofthe cyst studied. 
ttt The presence of
a prominent layer of glial tissue has been variably attributed to intra-uterine chronic
inflammation, 3re developmental defect of the glial cells 
rse and ischaemia 
t2'245. The cyst
wall may also contain abberant nerve fibres. 
ttt Thicker strands of collagen or blood
vessels with hyalinised walls may be seen passing across the cavity.
The pathological changes within the spinal cord parenchyma are less well studied.
Vascular changes, oedema and haemorrhages may be observed. 
376 Milhorat et al26e
recently performed a detailed study of 105 autopsy cases of nonneoplastic syringomyelia
and observed evidence of chromatolysis and Wallerian degeneration in all cases.
Neuronophagia andfatladen macrophages were a prominent feature particularþ in the
parenchyma of spinal cords with syrinxes which either did not communicate with the
fourth ventricle (central, nonconìmunicating) or were distinct from the central canal
(extra-canalicular). In the latter group of syrinxes, haemosiderinladen macrophages and
microglial cells were also particularly common in the walls of the syrirxes suggesting
previous trauma or haemorrhage.
1. 5. 3 Ultr astructural studies
Few ultrastructural studies of human syringomyelia are available. Ohama e/ a/ (quoted in
Chakrabortty et al rr) examined the autopsy material from 4 patients with Chiari Type I
malformations and noted evidence of axonal degeneration, demyelination with nude nerve
fibres as well as astrocytic proliferation. Hinokumaet al also observed the loss of neurons
in the spinal cord parenchyma adjacent to tumours. 
172
t2
1.6 Classifïcation of Syringomyelia
One of the earliest classification systems used has been the designation of syringomyelia
into 'primary' (or 'true') and 'secondary' (or 'acquired') forms. 
ls In primary syringomyelia,
the condition is thought to begin early in life, often in association with bony or soft tissue
anomalies. Subsequently, syringomyelia became classified according to the associated
lesions. Barnett r7 categorised the syndrome into five sub-types according to presumed
causal pathophysiology:
1. Communicating syringomyelia
a. Associated congenital anomalies at the foramen magnum
b. Associated acquired abnormalities at the skull base
2.Syringomyelia as a sequel of spinal arachnoiditis
3.Syringomyelia associated with spinal cord tumours
4.syringomyelia as a late sequel of trauma (post-traumatic cystic myelopathy)
5.Idiopathic syringomyelia
In contrast, Williams felt that the principal separation is between "hindbrain-related" and
"non hindbrain-related" (or "primarily spinal") syringomyelia. 
a3E Williams clearþ
13
appreciated the complexity of the pathogenesis of syringomyelia. He pointed out that
while the associated pathologies are likely to be causes of the syringomyelia, they were not
necessarily so. 
oo'For example, he argued that while hydrocephalus may be regarded as a
cause of syringomyelia when there is a wide communication between the fourth ventricle
and the syrinx, it may also be regarded as additional evidence of disease of the CSF
pathway. Thus the entire syndrome complex may be more accurately attributed to a
primary disorder such as head injury or meningitis. 
aa2In addition, Williams also
considered idiopathic syringomyelia to be extremely uncommon. When it occurs, it is not
uncommonly associated with meningeal fibrosis.
Logue and Edwards classified syringomyelia into 2 maintypes depending on whether there
was primary dilatation of the central canal, 'ot More recently, Milhorat and colleaguss 
26'
modified the classification to distinguish 3 types of spinal cord cavitations; 1) central canal
syrinxes (communicating with the fourth ventricle) 2) central canal syrinxes (non-
communicating) and 3) extracanalicular syrinxes (FIGURE l). While the concept of
communicating and non-coÍrmunicating varieties of syringomyelia is not new, 
103 Milhorat
and his colleagues made important contributions to the understanding of syringomyelia by
correlating the pathologicaVautopsy findings 
27r with extensive ante-mortem MRI studies
in subjects suffering from syringomyelia. 'ut They also proposed an algorithm based on the
MRI findings to assist in decision making during management of these patients. 
268
Other researchers have conceptualised syringomyelia in terms of the type of fluid present
within the syrinx. For example, Bunge 
3uo distinguishes 2 types of syrinxes. In the first
t4
type (which includes most cases of Chiari Type I and II malformations), there is free
exchange between the CSF in the central canal and the subarachnoid space. In the second
type, such a free communication does not exist and the fluid within the syrinx cavity




Figure l. Mìlhorat classífuation af syríngomyelìa: (A) non-communicating (central)
( B ) c ommunicating ( c entral ) ( C ) extra- canalicular.
1.7 Experimental models of syringomelia
The successful development of an experimental animal model will allow the clarification of
the pathogenesis of cyst formation. It will also enable therapeutic interventions to be
tested. 'on Unfortunately, despite extensive research, the quest for a clinically relevant
animal model remains a major challenge. A brief overview of the available experimental
techniques is included in the current work.
1.7.1 Arøchnoiditis
The earliest investigators attempted to establish animal models of syringomyelia by
injecting a variety of irritative substances into the cisterna magna of animals to induce
chronic basilar arachnoiditis. This resulted in hydrocephalus as well as spinal cord
cavitation. The agents used included combinations of fatty acids, sodium nucleinate, talc,
ethyl iodophenylundecylate as well as kaolin 
261
Later studies have largely utilised cisternal kaolin injections. Becker et al2s demonstrated
significant dilation of the central canals in feline spinal cords following cisternal kaolin
injections. Occlusion of the obex and frlum prevented syrinx formation which led the
authors to lend support to the haemodynamic theory of Gardner. Similar experiments were
subsequently reproduced in cats32n'"0, dogs 
r52 and rabbits 
uo. Histologically, there is
evidence of ependymal flattening with loss of cilia and villi as well as subependymal
oedema. These changes are associated with demyelination and axonal degeneration within
the spinal cord parenchyma.55
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In this model of experimental syringomyelia, it is clear that the central canal remains
patent. tt'ttt However, while hydrocephalus is necessary, it is not sufficient to result in
syrinx formation alone. Consequently, it has been suggested that kaolin may possibly have
other mechanisms of actions beyond simply producing hydrocephalus. James et al 
reo
performed intra-cisternal injections of silicone rubber instead of kaolin. This resulted in
significant hydrocephalus without the characteristic spinal arachnoiditis. No syrinxes
developed in any of the study animals. On the other hand, intradural or subarachnoid
spinal injection of kaolin also does not lead to syrinx formation. 
er
Using the same animal model, H;all et a/ investigated the effect of varying ventricular
pressure on the syringeal pressure by performing simultaneous in vivo measurements.
Their results suggested the existence of a ventriculosyrinx valve effect, which they
postulated may subsequently lead to progressive syrirx distension during transient
increases of intra-cranial pressure. "'
1. 7. 2 Post-trøumatic modek
In lg¿3,McVeigh created cavitary lesions within the spinal cords of dogs by crushing the
cord between the vertebral bodies and his finger after performing a thoracic laminectomy.
'u'However, Fehlings and Tator 
e3 credited Schmasus as the first to produce experimental
degeneration and cavitation of spinal cords of rabbits by the application of blunt trauma.
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Using a weight drop technique to induce severe spinal cord contusion in rats, Guizar-
Sahagun et al morerecently observed that cystic necrosis consistently led to well defined
cysts at 3 to 4 weeks post-injury. 
tot Similar findings have also been reported in the cat
63'423 aswell as rabbits 
60.
Cho et al60 noted that the rabbits in which they performed an additional subarachnoid
kaolin injection after inducing a traumatic injury to the spinal cord were more prone to
form syrinxes. The explanation for this observation is not known. Flowever, the authors
proposed that the injected kaolin resulted in an adhesive arachnoiditis which altered the
CSF circulation pathway although they failed to elaborate on their theory. This is believed
to lead eventually to the extension and coalescence of multiple small cavities which were
formed at the time of the initial injury. Other researchers have further suggested that the
tethering of the spinal cord may lead to a reduction in local spinal cord blood flow. 
370 This
may lead to the release of excitatory amino acids, which result in tissue damage and
subsequent formation of cavities within the spinal cord' 
3u3
1. 7. 3 Intr a-medullary ini ections
Williams and Weller 
a3r injected small volumes of saline into the spinal cords of 5 beagle
dogs. This was subsequentþ followed by sequential infusions of saline or cerebrospinal
fluid through an implanted catheter. Williams and Weller concluded that their findings of
spinal cord cavitation supported a haemodynamic concept for communicating
syringomyelia in the human. This experimental technique induced significant morbidity in
19
the study animals which included limping and spasticity of hind limbs, pain on injection as
well as scoliosis.
More recently, Milhorat et a|267 established an experimental model of noncommunicating
syringomyelia in rats (FIGURE 2). They performed microinjections of kaolin into the
dorsal columns and central gray matter of the C6 spinal cord. This led to reproducible
dilatation of the central canals which did not communicate with the fourth ventricle. The
central canal dilation was attributed to rostral obstruction by inflammatory cells and
proliferation of the ependyma and fibrous astrocytes, which subsequently prevented rostral
flow ofCSF.
20
Figure 2. Kaolin-induced nød.el of non-commanicartng syringomyelia in
the rat,
1.8 Theories of pathogenesis
1.8.1 Theories of Congenital Origin
Charles Prosper Ollivier d'Angers (1796-1845) first coined the term "syringomyelia" in
lg77.3o2 However, this pathological entity had been well recognised for atleast2
centuries prior to this. 
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According to Ollivier, syringomyelia arose from a developmental rest within the spinal
cord. '02 Subsequent authors held the view that the syrinx developed as a consequence of
incomplete fusion of the 2 folds of the primitive medullary groove which results in
disruption of the germinal cell layer. 
28'126'r63'22s'348
John Cleland (1835-1925) noted that the central canal was dilated in a patient with
hydrocephalus associated with spina bifida. 
u' Consequently, he suggested that this was
due to primary dysgenesis of the brain stem. Hassin 
r5e described "abiotrophY", a
developmental anomaly of the glia. He suggested that the glial tissue initially proliferated
but subsequently degenerated as it became walled offby proliferating connective tissue.
Mackay and Favill2ae similarly theorised that abnormal glial proliferation was followed by
degeneration and cavitation. Another view suggested that syringomyelia is a congenital
malformation which occurs as a part of the spectrum of dysplastic conditions. 'nt Tamaki
and Lubin 3tT later proposed that syringomyelia was a developmental anomaly caused by
imperfect formation of the central canal by primitive medullary epithelium. The defective
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cell rests subsequently undergo gliosis, with cavitation being a consequence of 'poor
nourishment'. Chiari 5e in describing the abnormalities at the craniovertebral junction,
postulated that syringomyelia represented a persistence of the physiological state of
embryonic hydromyelia. More recently, Netsþ proposed that syringomyelia begins as a
congenital intramedullary vascular anomaly, which subsequently becomes occluded or
ineffective. 2er This leads to tissue infarction and cavitation which is followed by reparative
gliosis or connective tissue proliferation.
1.8.2 Theories of Acquired Origin
1.8.2.1Hydrodynamic
The concept that hydrodynamic forces are significant in syringomyelia is not new. In 1862,
Gull described a patient with "hydromyelus" which extended from the fifth cervical level
down to the upper thoracic segments. 
roeHe attributed the atrophy of the spinal cord
tissue to the distension of the cystic cavity as the fluid accumulated within the cyst.
Later researchers such as Taylor and his colleagues 
3s suggested that CSF pressure may
be a contributing factor in the formation of syringomyelia. Lichtenstein believed that in
most cases of syringomyelia, the presence of congenital anomalies resulted in abnormal
CSF drainage from the ventricles which led to central canal dilation. 
228 However, Gardner
and his colleagues 
ll2'll3'lr4'll5'l16'll7'118'1le'tto were among the first researchers to set out
the hydrodynamic theory in a systematic fashion. They theorised that either a premature





pathological state of noncommunicating hydrocephalus. The obstruction may occur at the
exit foramina of the fourth ventricle but may also occur at the foramen rnagnum in cases of
tonsillar herniation. This leads to persistence of hydrocephalus and an enlarged central
canal. When the anatomical relationships are normal, the pulse wave in the ventricular
cerebrospinal fluid is conducted freely through the fourth ventricular foramina and is
dissipated in the subarachnoid space. However, any obstruction to the outflow from the
fourth ventricle will lead to pressure transmission down the central canal resulting in
dilatation, with CSF entering the obex in an arterial dependent "water hammer" manner.
With more severe forms, there is dissection of fluid into the parenchyma of the spinal cord.
Gardner believed that this was applicable to all cases regardless of pathology.
However, this theory was considered deficient by later researchers. The theory of Gardner
was challenged by Willams 
a3o who pointed out that the enormous dilation of cord cavities
in the presence of "modest" hydrocephalus was not consistent with the idea that the
arterialpressure wave was the prime distending force of the syrinx. Williams further
pointed out that the syringomyelic cord was often collapsed at myelography and at






Since then, the lack of continuity of the syringomyelic cavities with the fourth ventricle in
many patients has also been well recognised. 
to4'335'376'428 Even among patients with Chiari
malformation-related syringomyelia, few patients (approximately l0%) maintain an
opening at the obex. 
a2s Hinokuma and colleagues 




syringomyelia and concluded that the irregular and branching shape of the syrinx in Chiari
I related cases could not be explained on the basis of Gardner's theory.
In contrast, Williams and his co-investigators 357'430'431'432'433'434'43s'437'438'43e'44o'441'442beüeved
that the intermittent sharp rises in fluid pressure associated with central venous pressure
alterations are of fundamental significance. They proposed that venous distension resulting
from valsalva-type activities led to a pressure differential gradient between the central
canal and the subarachnoid compartments. This results in a "suck" mechanism, which
drives the CSF upwards from the spinal compartment past the foramen magnum into the
intracranial cavity. In the setting of partial blockage of the subarachnoid space at the
foramen magnum (as in hindbrain malformations), CSF is unable to 'return'to the spinal
compartment and is consequently forced through a patent central canal into the syrinx.
This requires all patients to have suffered at least a brief episode of hydrocephalus,
producing the initial dilation of the central canal. Once a cavity has been formed, the cavity
is said to enlarge by the process of "slosh", in which increased syrinx pressure during
valsalva procedures leads to dissection of the spinal cord tissue. The importance of sudden
changes in spinal venous pressure produced by coughing and straining in extending the
syrinx after the cavity had formed was supported by Du Boulay et aI86 -
While the anatomical basis of both Gardner's and Williams'theories appears identical, the
fundamental difference rests in William's proposal that the distension of the central canal is







contrast, Gardner's theory involves a steady rhythmical process associated with the'water
hammer' effect of transmitted arterial pulsation.
More recently, Oldfield et al performed dynamic MRI studies in patients suffering from
syringomyelia associated with Chiari Type I malformatio.rs. 'ot They observed abrupt
downward movement of spinal CSF and syrinx fluid in the upper portion of the spinal
canal during systole and upward movement during diastole. This led them to propose a
"piston like" effect in which the movement of the impacted tonsils during systole is
synchronous with sudden constriction of the cord and underlying syrinx. Consequently,
CSF is forced into the spinal cord from the syrinx thus expanding the cavþ. Terae et al3er
also studied the pulsatile movements of CSF in patients with Chiari malformations on
MRI. They found greater pulsatile movement of the hindbrain and spinal cord in these
patients in comparison with a control group. Subsequently, they have suggested that
normal downward movement of CSF in systole is impeded and the increased intracranial
pressure forces the medulla and tonsils downward. They postulated that the pulsatile
movements of the spinal cord act as a "vacuum pump" that extends the size of the syrinx.
l.8.2.2Ischaemia
Tauber and Langworthy 
38e observed that cavities formed within the spinal cord after
occlusion of the anterior spinal artery. Mclaurin et al26r performed cisternal injections of
kaolin in 13 dogs. This induced both hydrocephalus as well as spinal cord cavitation. They






vessels which led to spinal cord ischaemia. This theory was subsequently refuted by other
- - - ---r- - -- 16,17,153,248,435researcners.
Lichtenstein held the view that some cases of syringomyelia arose as a consequence of
ischaemic necrosis due to distortions of the cervico-medullary junction within an abnormal
posterior fossa. "tNetsky believed that ineffective intramedullary vascular anomalies led
to ischaemia and cystic necrosis within the spinal cord tissues. "t More recently in the
context of post traumatic syringomyelia, it has been suggested that haemorrhage into the
spinal cord at the site of injury is usually followed by localised arachnoid adhesions which
in turn leads to tethering of the cord, delayed ischaemia and impairment of CSF flow
within the subarachnoid space. 
16 Milhorat et al noted that many of the extracanalicular
syrinxes were located in the watershed zone between the anterior and posterior spinal
arteries and also suggested that there may be a vascular component to the inJury-'un
1.8.2.3 Tumours
A syrinx is associated with l5-58yo of intramedullary spinal cord tumours. 
r0'31e'36r'446
These tumours may include astrocytomas, ependymomas, haemangioblastomas, nerve
sheath tumours and less commonly metastases. 
18'438 The proposed aetiologies of
neoplasm-associated syringomyelia include faulty differentiation 
3t', spontaneous autolytic
liquefaction'ou, tumour haemorrhage 
t", local arachnoiditis 18, interference with tissue
fluid draina ge"'and secretion of fluid or an oedema-generating factor 
no''ut' Tumours




from the spinal cord.t"'t'u'2et'322'3r6F*+ramedullary compressive lesions may also lead to
syringomyeüa 
r8'2es although the mechanisms may be significantly different.
l.8.2.4Inflammation
For many researchers, inflammation within the central nervous system is largely confined
to immune-mediated diseases. "o Howerrer, it has recently been implicated in the
pathogenesis of a large variety of neurological conditions which include traumatic injury,
ischaemia, AlDS-related dementi a and Nzheimer's disease. 
tto
The consideration of inflammatory factors in the pathogenesis of syringomyelia is a
significant one. Certainly, syrinxes which form in association with diseases traditionally
regarded to have an inflammatory basis (e.g. multiple sclerosis 
26*) cannot be explained
adequately by current theories of syringomyelia.
However, the concept that inflammation may play a significant role in at least some
specific types of syringomyelia is not new. In 1945, Weil suggested that glioma-associated
hydromyelia may occur as a consequence of "inflammations of the the spinal cord with an
increased accumulation of fluid" or "the blocking of the upper medullary end of the central
canal". 
o" Feigin et al performed autopsy studies in 14 cases of syringomyelia and
concluded that the condition resulted from "a variety of destructive processes among
which edema is a major factor and inflammation, circulatory insufficiency and trauma
additional factors". 
ealn addition, they also noted that "microglial proliferation" was
present in the majority of cases studied. More recently, Baldwin and Malone, 
n in
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reviewing the pathogenesis of post-traumatic syringomyelia also suggested the possible
role of inflammatory mechanisms but did not elaborate further on the issue. Limited but
more direct evidence was provided by the study of Blagodat slcy et al .30 They detected
elevated levels of immunoglobulin G, M or A in the syrinx fluid in 16 of 26 patients. They
further observed that specific staining for Ig G was present in the pia mater during the
early stages of the disease. The authors concluded that syrinx formation possibly resulted
from the "synergic action of hydrodynamic and immunopathological mechansims". 
30
The predominant inflammatory cell type which has been most commonly implicated is the
macrophage. Human autopsy studies have shown that fat and haemosiderinJaden
macrophages are a common feature of non-communicating varieties of syringomyelia.26e
This is well supported by experimental data accumulated form animal research. In syrinxes
which form after cisternal kaolin injections, many macrophages are seen at the margins of
the syringomyelic cavity actively phagocytosing myelin. 
tu Similarly, intra-parenchymal
injections of kaolin into the rat spinal cord led to a florid local macrophagic inflammatory
response and a significant dilation of the central canal rostrally. 
26elnterestingly, similar
intra-parenchymal injections of blood were associated with a less marked macrophagic
response and did not lead to central canal dilation. 
265 Guizar-Sahagun observed that
macrophages in contused rat spinal cords persisted around the syrinxes up to 52 weeks
post injury. to* They suggested these macrophages exert "persistent destructive activþ,
although more selective and less intense than the initial necrosis".
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2 Macrophages and inflammation
2.L Definitions
The Dorland's Illustrated Medical Dictionary QTth Edition) defines a macrophage as "any
of the many forms of mononuclear phagocytes found in tissues". 
t Consequently, it is
necessary to stipulate the criteria which must be satisfied before a cell is called a
'mononuclear phagocyt.r. 
410'413 These requirements include morphological features, the
presence of certain cytoplasmic enzymes and staining with specific monoclonal antibodies.
ot' Othe. requirements include the presence of IgG Fc and C3 cell membrane receptors as
well as demonstrable phagocytic and pinocytic activity. It is generally accepted that a cell
must satisfy at least th¡ee of the above criteria before it is considered a mononuclear
phagocyte. a13
2.2 Mononuclear PhagocYte system
In 1924, Aschoffassigned the monocytes and macrophages to the reticuloendothelial
system. This system of classification was based on similarities in cellular morphology,
properties, origin and functions. 
u However, such a classification system subsequently fell
into disfavour as it became evident that cells such as fibrocytes and histiocytes are not as
similar as first thought.
More recently, Van Furth and his colleagues proposed that monoblasts, promonocytes,
monocytes and macrophages could be classified into the mononuclear phagocyte system
30
(NPS) 408'40e They felt that the concept of the MPS would promote research on the
physiology of macrophages, monocytes, and their precursors under normal and
pathological conditions, eventually leading to an improved understanding of certain
diseases and their subsequent treatments. 
arr
Since then, many more cells have been added to the list of mononuclear phagocytes based
on studies of cell kinetics and specific monoclonal antibodies. 
137'173' 180'181'413 While some
authors consider the resting microglia to be cells of the mononuclear-phagocyte series, 
ar3
this is controversial. 
255
2.3 Biology of the macrophage
2.3.1 Origin and kinetics
It is now almost universally accepted that tissue macrophages are formed in the bone
marrow. ot3 These cells are subsequently transported via the circulation to tissues where
they are destined to perform their functiorrs. 
ott'ot'In the adult, the earliest recognisable
macrophage precursor cell is the promonocyte. 
401'4t3Macrophage precursors subsequently
undergo several cycles of proliferation and differentiation in the bone marrow (approx 8-
l0 days). They then circulate as monocytes for l-2 days, 
uu'ott where they constitute3-5Yo
of the circulating leucocytes. 




Macrophages are detectable early in embryogenesis. 
l'7In the mouse, macrophages first
appear in the yolk sac on Day 9 of embryonic life. 
30sHaematopoiesis then shifts to the
fetal liver, peaking at Day 74 and subsequently to the spleen and bone marrow just prior to
birth. 308 They then accumulate in mesenchymal tissues during organogenesis as the
circulation is established (from embryonic Day l0). The developing brain appears to be the
first organ to be colonised with macrophages (and their precursors) atDay 12.368
Consequently, significant numbers of macrophages may be found in various sites including
gut, kidney and the central nervous system.306
2. 3. 2 Cellular turnover
Mature macrophages may be found in most tissues of the mouse; including
haematopoietic, lymphoid organs as well as other connective tissues. 
t" The turnover of
these cells in different tissues is variable. 
ott However, in the absence of any stimulus,
these cells are relatively long lived (weeks to montht). 
ott They are continuously replaced
by new haematogenous/bone marrow derived elements 
736'r37 although there may be low
levels of local replication 
137.
The ultimate fate of macrophages is not well understood. It is not known whether they
eventually die in the tissues of residence or migrate to another site. In the CNS, it has been
suggested that macrophages may possibly migrate to the perivascular space 
260 or to the
brain surface and subarachnoid space 
r3r en route to the local lymph nodes 
2e8'411. While
there is some evidence that macrophages can re-enter blood vesselst3t and reach the spleen
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340, recirculation of macrophages via peripheral blood does not appear to occur to any
significant extent 413.
2.3.3 ldentiJication of Tissue Møcrophages
The morphological features observed on light microscopy are among the least reliable
methods of identification. ter Both the morphology and antigen expression of tissue
macrophages vary in accordance with their state of activation and resident location.
4e'ret'220'3r2'4toHowever, regardless of location, most active macrophages display membrane
ruffles andlor folds, pseudopodia, filopodia, and a rough or bubbly membrane surface.
r6a'lel ¡11.ustructurally, macrophages possess abundant microfilaments and granular
endoplasmic reticulum, elongated mitochondria and numerous lysosomes and membrane-
dense bodies. 
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Consequently, a variety of histochemical and immunological techniques have been utilised
to assist in the identification and characterisation of tissue macrophages. It has been
suggested that the most reliable feature of macrophages is their phagocytic capacity. 
rer A
variety of agents such as dyes, colloids (e.g. Thorotrast) and enzymes (horseradish
peroxidase) have been used for this purpose. 
ret'3e6'42eMore recently, the technique of
fluorescent spheres has also been utilise6.220'3e2
Histochemical techniques largely target the hydrol¡ic enzymes involved in phagocytosis.
lnt These include acid phosphatase, non-specific esterase and aryl sulphatase. 
t64'232'236
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Until recently, positive staining of mononuclear phagocytes for nonspecific esterase was
considered by some to be the only characteristic which reliably differentiated between
these cells and other mononuclear cells at sites of inflammation. 
all
The more recent development of monoclonal antibodies such as F4l80 which are
considered specific for mononuclear phagocytes has also been particularly valuable.
174'2t5'4tt Other techniques are aimed at the detection of receptors for the Fc fragment of
IgG (Fc receptors), complement proteins (CRr and CR3 receptors), lysosomal antigens
(ED1-3) and acetylated low-density lipoprotein. 
80'83'r2e'r64't37'381'418 Several other
membrane glycoproteins (MAC-l, MAC-2 and MAC-3) have also shown some promise as


























































































































Table l. Immunohistochemical characteristics of microglia and macrophages. The
notation has been directly derivedfrom the original papers. -: negative, -,/+: inconsistent
staining. (+): occasional staining, +: weakly_p9!!t_r!:'-^++ or +++: strongly positive.
(t4ltL : ihite matter, GM : grey matter).t2r'r3o'277'28e'3e5'4r8
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2.3.3.1EDI as a macrophage marker
The ED series (l-3) of monoclonal antibodies was first cloned by Dijkstra and her
colleagues. 67'80'83 They are thought to recognise cells of the mononuclear-macrophage
lineage in the rat exclusively. to
In particular, EDI is generally regarded as a pan macrophage marker 83 although there are
notable exceptions. Subpopulations within the lymphoid organs such as marginal
macrophages in the spleen and subsinusoidal macrophages in lymph nodes either stain
weakly or negatively. 80
The EDI monoclonal antibody appears to recognise a heavily glycosylated protein of
97,oOO MW 80'8r'83, expressed mainly on membranes of cytoplasmic granules such as
phagolysosomes as well as on the cellular membrane 67. Differential expression of the
antigen may occur and appears to be correlated with the level of phagocytic/endocytic
activity. 22'67'81As the EDI antigen shares many similarities with the human CD68 antigen,
a role in antigen processing has been postulated. 8r'83
Within the CNS, macrophages may be reliably identifìed by EDI expression. soMore
recently, it has become evident that resting microglia only rarely express EDI
immunoreactivity. "'ttoHowever, upon activation, synthesis of the antigen can occur
leading to strong immunostaintng.23'r22'"'While granulocytes with weak EDI expression
36
have rarely been observed in peripheral blood, EDI positive granulocytes have never been
observed in tissues. 
8a
2.3.4 Acute Inflammation
Large numbers of monocytes accumulate at sites of local inflammation and transform into
macrophages. t'uMonocytes accumulate early in the presence of inflammation. 66 Both
parabiotic and adoptive transfer experiments suggest that monocytes are the main source
of recruitment into peripheral organs. t37'4to'4r3'4te In short lived inflammation where the
inciting stimulus is removed, macrophages are eliminated quickly (presumably either by
death or migration into the lymphatic system). When inflammation persists, macrophages
typically become the predominant cell type within 48 hours. 
uu This involves the interplay
of several processes which include:
(1) continued recruitment of monocytes from the circulation
(2) local proliferation of macrophages, and
(3 ) immobilization of macrophages. 
uu
It is thought that a small, variable but significant component of the macrophagic response
arises from the replication of local macrophages. 
36'37'7e'186'2e3'362'36e'4o7'an'aß'a20'a2t75t
process typically occurs after the second duy ot'
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2. 3. 5 Chronic inflammation
The tissue macrophage is regarded as the "prima donna of chronic inflammation". 66As the
inflammation process extends into a chronic phase, the macrophages may interdigitate to
form clusters or granulomas. l3u
Chronic inflammation can be classified into 2 types depending on the presence of
granulomas. ot'In general, bone marrow derived monocytes are recruited to sites of
persistent inflammation ar3 with a small component arising from the local resident
macrophages ut. Irritant material which is not easily degradable results in the formation of
granulomas.se's7'68'6e'127'382 In some cases, the macrophages may coalesce to give rise to
mutinucleated giant cells. 136 These are formed by the fusion of newly arrived monocytes
with existing macrophages rather than nuclear division of macrophages. t''0"
2.3.6 Functional aspects of macrophages
Tissue healing generally involves macrophages. uu Mac.ophages are believed to have a
fundamental role in the maintenance, restoration and defense of damaged tissues
(FIGURE 3). rt+'rst Foflowing an injury, macrophages are activated and migrate into the
affected region. t5t While clearing up cellular debris and necrotic tissue, they secrete
factors which are necessary for tissue healing to occur.
Macrophages are thought to have key roles in initiating immunological responses and
antigen presentation (FIGURE 3). a26Macrophages may become 'activated'. 66'426 This
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metabolism and phagocytic ability. 
66 In vitro studies of resident macrophages isolated
from the peritoneal cavity of the mouse demonstrate little microbicidal or tumouricidal
activity.
However upon exposure to lymphokines produced by T-cells, macrophages upregulate
their activity markedly and are subsequently capable of direct antimicrobial as well as
tumoricidal functions. 
026 The'activation'process is complex and involves signals such as
cytokines (e.g. IFN-gamma), bacterial endotoxins and ECM proteins like fibronectin. 
66
Macrophages express receptors which are capable of binding particles by both
immunological and nonimmunological mechanisms. 
136'3244s effector cells, they are
capable ofsecreting products such as neutral proteases, acid hydrolases, growth factors
(PDGF, EGF, FGF, TGF-beta), prostaglandins, oxygen free radicals , nitrogen oxide and
inflammatory cytokines such as IL-I, IL-6 and tumour necrosis factor-alpha.7t'e0'r57'2e0
Furthermore, macrophages can also act as antigen presenting cells to lymphocytes when
they express MHC Class II molecules. 2s6'415
The ability of macrophages to scavenge cellular debris and re-model the extracellular
matrix has also been considered to be crucial to embryonic development. 
308 These cells
may potentially have widespread influences on angiogenesis, gliogenesis and neuronal
development within the central nervous system. 
308
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2.4Macrophages in the Central Nervous System
The CNS is traditionally regarded as an immunologically privileged site. This has been
attributed to the presence of a blood-brain barrier. "r This is consistent with the very low
numbers of 'classical'macrophages which are present within the parenchyma of the normal
CNS.
However, some researchers hold the view that a population of resident macrophages exist
in a// tissues of the body. "o In line with this view, they believe that the microglia are
resident macrophages of the CNS which possess a highly differentiated morphology but
markedly downregulated phenotyps. 308'3 l3'atr
Apart from the microglia, specific subsets of macrophages have also been described.
These include the perivascular macrophages and macrophages of the choroid plexus and
meninges, each with somewhat different phenotypic properties. 308'313 The role of these




The microglia represent a class of glial cells within the CNS. They were first discovered
independently by ñssl and Robertson in 1899. 
13' 2t5 Nissl in particular described them as
Stcibchenzellen or 'rod cells'.rou Rio Hortega later added extensively to the body of
knowledge in his classical work in 1932.334
The peak of microglial development during embryogenesis occurs in the first 2 post-natal
weeks.332 At maturity, microglia comprise up to 20o/o of all glial cells .27 In humans, these
cells constitute about l3Yo of theglial population .ruo This is comparable to the mouse, in
which microglia constitute between 5-L2yo of all mouse CNS cells .205'3er Lawso¡ et al
estimated that the brain of the mouse alone contained 3.5 x 106 microglial cells.2ra
3.2 "THE CELL"
Microglial research has accumulated exponentially in recent years. Graeber estimated in
1993 that 50% of the published literature has been published after 1985 .145 The most
current MEDLINE search reveals that a total of 3142 microglia-related papers have been
published since 1966. More thang}Yo of these occurred after 1985. Consequently, it is not
surprising that some scientists have nominated the microglia as "T[IE CE,LL" in the
Decade of the Brain.ras
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3.3 The microglial debate
The microglial cells have continuously provoked much debate and research since their
discovery. Virtually every aspect, including their ontogeny, functions in both physiological
and pathological environments have been subjected to controversy. Until very recently,
even the very existence of these cells had been questioned by some scientists.2ou Ho*e',re.,
it is now widely accepted that this particular class of cells possesses unique features .273
Streit er a|u' Ittghlighted 3 contentious but inter-related issues in the'microglial debate'.
These included: (1) the embryogenic origin of microglia (2) the microglial contribution to
the macrophagic response in traumatic injury of the CNS (3) the origin of proliferative
microglia following peripheral nerve injury. The former two points are particularly
relevant in the current research and serve as a focal point for a literature review.
The current work does not set out in its primary aim to address the basic biology of
microglia. However, these properties are intimately related to their proposed roles in the
CNS under both normal and pathological conditions. An attempt has been made to
provide an integrated view, with regards to their relationship to macrophages as well as
their possible pathogenetic roles in pathological conditions of the CNS.
3.4 Nomenclafure
One of the difficulties in discussing microglia has been the imprecise use of this term.78
When del Rio-Hortega originally used this term, it was purely descriptive and hence
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included other cell types such as oligodendrocytes and small astrocytes.Ts However in
recent years, it has been considered to more specifically refer to intrinsic glial cells within
the CNS with a characteristic morphological and antigenic phenotype.
3.5 ClassifÏcation
The diverse nomenclature used in the literature has subsequently led to much confusion.
However, it would appear that there are at least 2 sub populations of microglia. Based on
morphological features, these cells may be classified into;
(l) ramifiedmicroglia (resting microglia), found predominantly in the white matter
postnatally, and
(2) amoeboid microglia (brain macrophages, microgliocytes or precursor microglia) found
in the grey and white matter perinatallyls4'275'2e3'3e4'400
The terms of 'ramified' and'amoeboid' depict only the morphological subtypes of
microglia. They do not describe the functional state of these cells.sa Although the
relationship of the amoeboid to ramified microglia remains unclear, it has been speculated
that a proportion of the amoeboid microglia is transformed into ramified microglia during
CNS development. 
rs2'235 Imamota and his colleagues initially suggested that the ramified
microglia were derived from their amoeboid counterparts.rst'tt' Ling and his colleagues
observed that during CNS development, the increase in ramified microglia was associated
with a concomitant decrease in the amoeboid microglia. 
23t'236In 
a further set of
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experiments, they noted that following intravenous injections of carbonJabelled
mononuclear cells into early postnatal rats, carbon labelling was observed in both the
earlier amoeboid as well as the later ramified microglial cell types. Interestingly, Suzumura
et al demonstrated that cultured microglial cells may be chemically-induced to transform
reversibly into either amoeboid or ramified forms in response to specific
cytokines/factors-37e This provides further support for the concept that the amoeboid and
ramified microglia are essentially variants of the same cell type.
This simple classification of microglial cells was subsequently expanded upon by Flaris and
Hickey 1993.e8 They further distinguished:
(3) activated microglia (cD1lb/c++ , cD4+, MHC II+), found in areas of secondary
reaction as a consequence of nerve transection and CNS inflammation. In contrast, the
ramified microglia are CDl Tblc+, CD4-, MHC II--
(4) reactive (phagocytic) microglia, found in areas of trauma, viral infection or neuronal
degeneration
Murabe and Sano28' fu.ther described another microglial sub-type which they considered
to be restricted to the early postnatal period;
(5) a round cell form, which is smaller and exhibits pseudopodia but no other cellular
processes
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These latter forms of microglia are also thought to correspond to variable morphological
and functional states of a single cell type although the exact nature of their
interrelationships is unclear. 
rer
3.5.1 Ramified microglia
The ramified microglia form an even mosaic throughout the central nervous system.sl'lel'
275,277,278, 
"'Rio-Hortega first described these cells in silver stained preparations at the
light microscopic level in 1932.334 On fight microscopy, the ramified microglial cell
possesses a small oval cell which is characterised by an elongated soma with 2 or more
primary processes projecting from both poles of the cell.275 Dense or inclusion bodies
(lysosomes or phagosomes) may be found within the scanty cytoplasm.st'216'283'284'28s
IJltrastructurally, the small or angular nucleus contains coarse chromatin at the periphery
and a small nucleolus .31 Small granules and rough endoplasmic reticulum may be found
within the scanty cytoplasm at either pole.
There is conflicting evidence with regards to the precise distribution of ramified microglia
within the central nervous system. Some regard the microglia as a uniform population of
cells with equal density in both the white and grey matter.21 Others however have shown
that regions with the highest density of microglia such as substantiantgra and the ventral
pallidum demonstrate a 5 to 6 fold difference from those in the brain stem and cerebellum
.2t4,3t3It is not entirely clear whether this relates to variations between species of animals.
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However, there is general agreement that the dendritic fields of microglia do not overlap
and the entire neuropil is uniformly occupied by the ramified processes of microgli a .27' 
r24
3.5.2 Amoeboid microglial cells
The amoeboid microglial cells occur transiently during embryogenic CNS development
.r87'3e7 In rats, they arise in the last week of gestation in rats and disappear during the
second postnatal week.l3o'tet'270 Similar findings have also been reported in mice.lT' They
are typically located in clusters within the white matter of the developing telencephalon
.184, 
r87 In particular, Ling and Tan23l noted that these round amoeboid microglial cells are
particularly prominent in the corpus callosum of early postnatal rats.
The functional differences of amoeboid cells are not entirely understood. However, they
are believed to be involved in the phagocytosis of apoptotic or degenerating cells within
the developing CNS.e5' 
308' 313 It has further been suggested that amoeboid microglia may
release peptides (including IL-1,GPF-2 and GPF-4) which influence the growth and
proliferation of astroglia. r3o
3.6 Perivascular microglia
The term'perivascular microglia' deseryes special attention as it appears to have various
applications in the scientific literature.2a Hickey and Lassmann considered that the
"perivascular microgli a" , "pericytes", "fluorescent granular perithelial cells" and
"perivascular monocytes" may possibly refer to the same cell type.lTo Bauer et al shared
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this view but further suggested that the 'perivascular cell' is also the same cell.2a Risau and
Wolburg proposed that these cells may be an integral part of the blood-brain barrier.33e
In contrast, other researchers believed that this was tantamount to "indiscriminate use of
terminology".la2 Graeber and Streitra2 strictly defrned the 'perivascular microglia' as true
microglial cells which were located in the proximity of blood vessels outside the basal
lamina. They considered these cells to be distinct from'pericytes'which form part of the
vascular wall within the basal lamina. Furthermore, these cells are also distinct from the
'perivascular cells', which may morphologically resemble'pericytes' but are better
understood as a distinct population of CNS resident macrophages. These views were
supported by Berry and Butt.27
3.6.1 Perivascular cells
The'perivascular cells' are located outside of the CNS parenchyma proper and are
separated by the basement membrane and the glial lamina limitans.2T They are relatively
large, spindle shaped cells which are not in direct contact with neurons.2t These cells may
be found either in the Virchow-Robin spacerTo or along capillaries and small venules
between the endothelium and basal lamina of blood vessels.2T'r42'r10 They can be identified
positively by the monoclonal antibodies EDl, ED224't4r'r42 as well as OX-l and OX-42r1o.
Hickey and Kimura demonstrated that in rat radiation bone marro\r/ chimeras, these cells
are continually renewed from the bone maffow every few days. Consequently, they also
suggested that the perivascular cells may be considered as part of the mononuclear
phagocyte system.r6s
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While perivascular cells may express MHC class II antigens in the absence of pathology,r6s
those which do not express these antigens constitutively may become MHC class-Il
positive after intravenous administration of interferon-garnma."o Consequently, they have
been implicated as antigen presenting cells within the central nervous system. When
stimulated under certain situations, they may also be positive for IL-l,406 intercellular
adhesion molecule-1 and leucocyte function antigen-1,24 allowing them to interact with
leucocytes as they enter the perivascular space. Furthermore, these cells may also express
cD4.280
3.7 Origin of microglia
The ontogeny of microglia is controversial. Rio Hortega (1932) initially proposed that
microglial cells are of mesenchymal origin.3" He hypothesized that they were derived from
the invasion of mesodermal pial elements during embryogenesis. This theory was widely
accepted by many later investigators.a0'tt Ho*ever since then, a number of alternative
theories have been put forward to explain the origin of microglia.
3. 7. I Neuroectodermal theorY
Another long standing opposing theory states that the microglia are derived from
neuroectodermal tissues.22a Rydberg believed that ramified microglia were derived from
the subependyma of the lateral ventricles.3a3 In studying gliogenesis in the optic nerve,
Vaughan and his colleagues concluded that the ramified microglia were derived from
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neuroectodermal matrix cells.360'416'4tl Fujita and Kitamuraloe used the silver carbonate
method to stain tissue sections of both rabbit and human brains. They observed staining of
the glioblasts with their intermediate forms up to the so called microglia, oligodendroglia
and astrocytes. Consequently, Fujita and Kitamura believed that these cells originated
from the subependymal glioblasts. This view has also been supported by more recent
. -r- - -- 92, 109,200,346researcners.
On the other hand, some notable investigators"t't" have considered this theory to be
unacceptable, arguing that common markers between these glial elements have not been
demonstrated by immunohistochemical methods."t
3.7.2 Pericytal origin
yet another view suggests that microglia are of pericytal origin.tq 
278 Mori and Leblond
postulated that the pericytes associated with blood vessels migrate into the neuropil due to
the discontinuous nature of the overlying basement membrane.t'* Onthe other hand, while
Boya et a/ considered that microglia arelargely derived from "the meningeal membranes
and the vascular adventitia", these cells may also arise from the pericytes.o' Interestingly,
Ling and Wong pointed out that the pericytal theory may also be consistent with a




The theory of a haematopoietic/monocytic origin was first put forward by Juba and his
colleaguesrn''ton after they noted that the appearance of ramified microglia coincided with
the vascularisation of the brain. It represents the most widely accepted theory to date.
Several criteria are expected to be fulfilled to establish the monocytic origin of
microglia.3ot''ot These include evidence that:
(1) bone marrow derived cells enter the CNS and adopt the morphology of microglia
(2) monocytes transform into microglia
(3) microglia express antigens which may be restricted to the monocytic lineage.
A review of the literature suggests that all of these criteria have been satisfied.3o7
3.7 .3.1 Developmental studies
A number of developmental studies have lent support to the theory of monocytic origin of
these cells. Dunning and Forth observed that cultured monocytes \¡/ere capable of
transforming into cells which resembled ramified microglia.sT lmamoto and Leblond
described amoeboid microglial cells in the postnatal corpus callosum of the rat which share
similar ultrastructural features to monocytes. 
I 82
Ling injected carbon particles into the circulation of 3 to 5 day old rats and demonstrated
the labelling of amoeboid microglia.233''35 It was thought that the monocytes had
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phagocytosed the carbon particles prior to infiltrating the corpus callosum. Ling238
subsequently directly injected carbon labelled monocytes from donor Lewis rats into early
postnatal syngeneic rats. Similarly they found carbon labelled microglia in the postnatal
corpus callosum.23'' "t These cells disappeared within 2 weeks postnatally. This was
associated with a concomitant increase of ramified microglia suggesting a precursor and
progeny relationship."t While it has been suggested that the apoptosis in neonatal brains
may lead to chemotactic signals for the entry of monocytes into the CNS, direct evidence
for this is lacking.313
Histochemical studies using the rat monoclonal antibody F4l80 and other antibodies
directed against the Fc and complement type 3 receptors (present on monocytes and
macrophages) have documented large numbers of macrophages in the mouse brain
prenatally which progressively developed morphological features typical of ramified
microglia.2rs,226Incombination with autoradiographic techniques, Lawson et al fu¡het
observed that even in the adult mouse brain, the slow turnover of microglia is maintained
by division of resident microglial cells as well as entry of monocytes into the CNS .2rj





3.7 .3.2 Chimeric studies
Another experimental approach has involved the use of rat radiation bone marrow
chimeras. Irradiation of animals at high doses eliminates the haematopoietic precursors
within the bone marrow. Subsequently, they are reconstituted with bone marrow cells
lr
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harvested from congeneic donor animals which carry a cellular marker distinct from the
recipient. Using this technique, small numbers of bone marrow-derived cells have been
demonstrated within the brain and spinal cord.73'168' 
r70 Hickey and his colleagues further
observed that some of these cells subsequently adopt the morphology of microglia.r6s'r70
In contrast, Matsumoto and Fujiwara were unable to reproduce these findings in their
chimeric rats over a study period of 24 weeks."t However, Matsumoto and Fujiwara
cautiously pointed out that their results did not exclude the bone marrow origin of
microglial cells as the influx of haematogenous precursor cells may be largely confined to
the perinatal period. While definite evidence is lacking, there is general agreement that the
microglial turnover in the postnatal period appears to be very low.
3.7.3.3 Immunohistochemical studies
Much of the initial opposition to the monocytic origin of microglia had been centred on
the apparent lack of antigens which are common to monocytes, macrophages and
microglia.2eT'402'4M This no longer appears to be a valid criticism. It is known that the
microglial cells are capable of upregulating their expression of certain antigens depending
on their state of activation. There is also accumulating evidence that alarge panel of
antigens are shared by microglia, monocytes and macrophages.es' 
308 Certainly, microglia
express most of the antigens which are expressed by monocytes .275'2E6' 
308' 30e' ¿104
3.7.3.4 Entry into the CNS
At present, the site and mode of entry of haematogenous precursors into the central







specific blood vessels or migrate within the parenchyma after these cells have left the
circulation. Ling and Wong have suggested these cells may enter through, (l) the
endothelial wall of blood vessels (2) transependymally and (3) through the pial surface.237
Perry et al notedthat the initial influx of F4l80* cells into the embryonic mouse brain is
closely associated with the blood vessels.3ou Others have suggested that monocytic entry
may occur specifically through local blood vessels within the corpus callosum and other
regions of the developing brain where cell death naturally occurs.t'" Other sites of entry
suggested have included the transitory cavum septum pellucidum or subependymal
cysts.l"' aot
Boya and colleaguesa2'03 described the immigration of macrophagic meningeal cells into
the brain parenchyma to become ramified microglia. While this may initially appear to
contradict the monocytic theory, meningeal macrophages are also known to be derived
263ilom monocyres. More recently, Kurz and Christ2o7 studied chick-quail blood chimeras
using a parabiotic technique. They concluded that the phagocytic haematopoietic cells
originate largely from the yolk sac and invade the embryonic pial surface directly without
involvement of the vascular circulation.
The prevailing view states that monocytes enter the CNS during a confined perinatal
period to form microglia. Beyond the fetal period, these cells become macrophages and do







3.8 Functions of microglia
3.8. 1 Normal conditions
The in vivo functions of resting microglia in the normal adult CNS remain enigmatic.r2a'r38
A number of theories have been proposed.
3.8.1.2 Immune surveillance
The combination of macrophage-like immunophenotype, highly branched morphology and
distribution within the CNS has led some to suggest that microglia form a network of
immuno-competent cells which are adapted to the architecture of the CNS.t3'to'These
researchers regard the microglia as a network of immune alert resident macrophages
which are capable of immune surveillance and'ftrst line defenc"t.204'2os The early microglial
activation which follows an injury to the central nervous system is consistent with this
hypothesis.
3.8.1.3 Tissue maintenance
It has also been proposed that the microglia may also have a constitutive role in
"cleansing" extracellular fluid in the CNS and monitoring changes in the extracellular
milieu.2O5'327'3e5 This suggestion is largely based on observations of high levels of
pino cyto si st'7 and ob served patterns of motility. 
3e s' 44e
Ramified microglia may contribute to tissue maintenance by removing cellular metabolites




damaged cells.3ee They may also limit the spread of diffusable neurotransmitters or
modulators within the extracellular fluid.3e5 A role of microglia in neurotransmitter
metabolism has similarly been suggested by other investigators. However, the supportive
evidence for these microglial functions is lacking.
3.8. 1.4 Neuronal/Glial support
The ability to produce growth factors such as transforming growth factor-beta, platelet
derived growth factor, epidermal growth factor, insulin-like growth factors and basic
fibroblast growth factor suggests that microglia play a potentially trophic/supportive role
for glia and neurons. 
t'Cultured microglia cells are also capable of secreting NGF, upon
challenge/stimulation with LPS, cytokines interleukin-lbeta and tumour necrosis lactor.162'
2s0,273 These further support a major neurotrophic role during development and neuronal
regeneration.
3. 8. 2 Pathological conditions
3.8.2.1 Effector fu nctions
Rio Hortega noted that microglia had the ability to transform into macrophages.33s While
this is somewhat controversial, it is now widely accepted that activated microglia actively
phagocytose cell and tissue debris which may includemyelin.2TT'3e5'44e
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Mcroglia can participate in both antibody-dependent cellular cytotoxicity via their Fc
gamma-receptors as well as complement-mediated endocytosis.3o6'403' 
418 During the
process of antibody-mediated demyelination, activated microglia are capable of lysing
antibody coated targetcells via interaction of Fc365 and complement receptors with
immune complexes and complement opsonised antigens.
Microglial cells are well placed to act as ef,lector cells within the central neryous system.272
When exposed to IFN-gamma and endotoxin, the microglial cells produce tumour necrosis
factor alpha.and develop tumour cell cytotoxicity.r06'ot' Other in vitro studies have further
demonstrated that microglia contain superoxide anions and nitric oxide which may be
released upon interferon-gamma (IFNgamma) stimulation'38' 
58' 64'te3' aa6 Futhermore, they
are capable of secreting proteases, arachidonic-acid derivatives, excitatory amino acids,
quinolinic acid and c¡okines.r2'167't11' "'Some of these liberated agents have a direct
cytocidal effect. For example, free oxygen radicals released by microglia have a neurotoxic
effect in co-cultures of neurons and microglia.3" Other neurotoxins are less well
r 133- 134
delmeo.
3.8.2.2 Local vascular regulation
.Cultured microglial cells provide a rich source of prostaglandin E2, prostaglandin Dz, êod
thromboxane Az when challenged with lipopolysaccharide. This may further be augmented
by beta-adrenergic activation.2tt It has been suggested that thromboxane secreted by




Microglial involvement in tissue healing and modelling has also recently been proposed
based on limited evidence. TGF-ßl is produced by macrophages and microglial cells after
a penetratin g injury.22e It strongly inhibits astrocytic proliferation and suppresses the
mitotic effect of FGF and EGF on astrocytes. This may promote tissue repair by reducing
astrocytic scar formation. Plasminogen which is also secreted by microglial cells leads to
neurite outgrowth in vitro,185'28e thus further implicating a role for microglia in proteolytic
processes involved in tissue remodelling.
3.8.2.4 " Synaptic Stripping'r
Following facial nerve axotomy, the microglia proliferate, particularly in a perineuronal
position. They subsequently ensheath the injured motor neuron, interposing processes
between afferent synaptic terminals and the neuronal surface.35 This process is now known
as'synaptic stripping'.27 The physiological significance is unclear although it has been
suggested that neuronal energy expenditure is minimised by cessation of the
"transmission" function."e'Synaptic stripping' may also influence synaptic reorganisation
of injured motor neurons."
3.S.2.5 Neuroprotective functions
Microglia may potentially exert neuroprotective functions on neurons although this has
been particularly difficult to evaluate in vivo. Indirect supportive evidence cited has largely
been based on the observation of potentially neuroprotective agents which are released by
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microglial cells. For example, the production of nitric oúde delays neuronal death in
ethanol-induced necrosis of the rat striatum."u Other agents such as PGE2 may potentially
have multiple effects on APCs and T lymphocytes which eventually result in
neuroprotection.
He et a/r6r performed sciatic neurectomies in athymic mice which congenitally possess a
significantly lower number of microglia. They found that the loss of motor neurons
occurred faster than standard BALC/c mice which had undergone the same procedure.
They concluded that these results suggest a neuroprotective function for microglial cells
although the extent of motor neuron cell loss were no longer significantly different by day
15. On the other hand, when the microglial proliferation following a crush injury to the
hypoglossal nerve was aborted by intraventricular infusion of cytosine-arabinoside, there
was no observed difference in axonal regeneration.3sa
3.8.2.6 MHC II upregulation
The low level of MHC II expression within the central nervous system is traditionally
thought to be consistent with the view that the brain and spinal cord are immunologically
privileged sites.27
Following both inflammatory and non-inflammatory lesions, MHC class II antigens may be
rapidly upregulated in activated microglia.2oe'276'3s4' 
37e Systemic or intrathecal infusion of
interferon-gamma leads to upregulation of MHC class II antigens in microglial cells.raT
Similarly, newly cultured microglial cells which are negative for class II antigens of the
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major histocompatibility antigen complex also became Ia* when treated with IFN-
106gamma.
However, MHC class II antigen expression is complex and varies even between different
strains of rats. In the brains of Lewis rats, the MHC II antigen expression is usually low in
normal conditions and is mainly found in macrophages in the leptomeninges and choroid
plexus, perivascular cells, white matter of cerebellum and the white matter of the lumbar
spinal cord.21 In contrast, the microglia of adult Brown Norway rats are constitutively
MHC Class II positive.3s3
MHC class II expression by APCs is essential for the activation of CD4* T cells.358
Typically, these antigens are presented with the processed antigens in conjunction with
other surface co-stimulatory molecules such as the B7 molecule found on antigen
presenting cells.27 This leads to the stimulation of antigen-specific T lymphocytes.
However, whether the upregulation of MHC class II antigen expression on microglia
reflects an increased capabilþ of antigen presentation remains unknown. In contrast, it
has also been suggested that MHC class II upregulation in the absence of co-stmulatory
molecules may protect the CNS against immune mediated injury.tt'"'"
The current literature is conflicting. On one hand, microglia derived from neonatal brains
present antigens effectively in experiments simulating in vivo conditions.2 On the other
hand, while adult microglia also express costimulatory molecules,BT.2,ICAM-I, and
CD40 and could be induced to express MHC class II antigens, they failed to present
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antigen.52 It is possible that the maturity/age of the microglial cells have an impact on their
ability to present antigens although further studies are required to clarify this.
peripheral nerve axotomy similarly leads to rapid upregulation of MHC class II antigens'
This is predominantly restricted to areas of primary projection.tte It has therefore been
suggested that this high state of immune alertness may facilitate delayed hypersensitivity
reactions rather than antigen presentation functions.27
3.9 Microglial response in experimental paradigms
3.9.1 Introduction
Microglial cells are widely regarded as the resident macrophages of the CNS.307'308
However, in many neuropathological conditions , it is not known whether the increase of
macrophages is due to proliferation of the resident microglia or to the influx of
monocytes.'on This is because the respective cell types cannot be differentiated based on
morphological characteristics and cell surface antigens.2se Consequently, some researchers
have even resorted to a cautious approach using terms such as "microglia/lVfø'! to describe
the inflammatory infiltrate within the central nervous system.
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3.9.2 Cranial nerve lesions
3.9.2.1 Facial nerve axotomY
The study of the microglial response to CNS injury has been a challenge. Experimental
animal models which involve penetrating injuries are by definition, associated with a
disrupted blood brain barrier. Hence, it becomes difficult subsequently to delineate the
local microglial responses from the peripheral macrophagic/monocytic comp onent.277
The facial nerve axotomy model is thought to allow the examination of the microglial
activation/proliferation in the absence of haematogenous cells by maintaining an intact
blood brain barrier.'ot This model involves the transection of the facial nerve, which results
in a retrograde, non-lethal injury of cell bodies within the facial nerve nucleus. 
r3s' 205 Facial
nerve compression leads to similar but possibly less marked changes.'a2In addition to the
preserved blood barrier, this model has the added advantage of creating a well defined
and reproducible lesion at the level of the brain stem which is away from the site of direct
277
mJury
Following facial nerve transection, the resident microglia proliferat et3e'205 with little
contribution from haematogenous phagoc¡es.2eó They begin to express macrophage
related antigens such as complement receptor 3, vimentin, MHC-I and II, MUC l0l,
MUC 102 epitopes and co-stimulatory molecules such as B7-lTNF-alpha and several cell
adhesion molecules including thrombospondin. 
taO'20s'37e The microglia also begin to
upregulate cytokine production .ro1't08'277 This process is blocked by simultaneous
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administration of the cytostatic agent adriamycin which is thought to inhibit microglial
differentiation and proliferatio n.t40' 
27 4
In this model, the facial motor neurons eventually regenerate the injured axons. The
microglial cells become activated but not phagocytic.3s' 
20s In contrast, when neuronal cell
death is induced by the injection of ricin into the facial nerve, the microglia rapidly
transform into macrophages to remove neuronal debris.377'378'37e' 
3to This is accompanied
by further increase in MHC Ia antigen expression and de novo of EDI and ED3
macrophage antigens. 
laa' 3es
Hence, the process of microglial activation appears to occur in graded phases which are
under strict control in vivo.2ot While cell death results in significant transformation of
microglia into brain macrophages, the precise triggers and signals which influence this
process remain poorly understood.
3.9.2.2 Other similar models
George and Grifün transected the lumbar dorsal roots just proximal to the dorsal root
gangliain rats.r25 Following this procedure, early microglial activation was readily
detected; peaking at 3 days within the dorsal columns. In contrast, round macrophages
were not detected until days 18-27.Importantly, they believed that these latter cells had
originated largely from endogenous microglia. A similar activation response in microglia is
also observed following sciatic neurectomyle6' 
280 and hypoglossal nerve transection .332'35e
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In the latter model, Svenson and his colleagues demonstrated that the infusion of cytosine-
arabinoside into the fourth ventricle or cisterna magîa leads to cessation of microglial
proliferation (and secondary astrocytic activation) following hypoglossal nerve
transection.3s4' 
38s
3.9.3 Optic nerve lesions
Schnitzer and Scherer demonstrated that within several days of transecting the optic nerve
in rabbits, there was increased number of nucleoside diphosphatase (NDPase) labelled
microglial cells within the inner plexiform layer, nerve fiber layer as well as the outer
plexiform layer."o Using a combination of ff4-fnymidine labelling and X-irradiation (to
exclude the participation of haematogenous cells), Lawson et al concluded that the
majority of macrophages responding to Wallerian degeneration were of endogenous
microglial origin.2r6
3. 9.4 Ischaemic lesions
Following an ischaemic injury, the microglia also respond rapidly. Transient forebrain
ischaemia (4 vessel occlusion for 25 minutes) in the rat led to microglial activation within
minutes as evidenced by an upregulation of GSA-I-B¿ lectin-binding sites.27e This became
very pronounced at 24 hours and was maximal at 4 to 6 days. In the hippocampus, a
similar response was observed within hours. Activated microglial cells persisted up to 4
weeks.
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Ischaemia induced in other regions of the brain by middle cerebral arterial (MCA)
occlusions also result in a microglial response in the affected cerebral cortex within l8
hours."e In contrast, the recruitment of haematogenous cells occurs later. Garcia and
Kamijyo described alarge influx of monocytes at7 and 16 days after permanent MCA
occlusion in primates. 
lll
Such a pathological response also extends beyond the region of primary insult.277 Regions
of the brain which suffer from retrograde injury similarly demonstrate microglial
activation.2TT Following unilateral MCA occlusion, progressive microglial activation was
subsequentþ noted in the contralateral cortex and hippocampus and the spinal cord
(cortico-spinal tracts).'*t However, this secondary response is slower, of a lesser
magnitude and possibly non-fatal .277' 
28t
Despite the clear demonstration of microglial activation following ischaemia, whether
such a response is harmful or potentially beneficial remains inconclusive. rWhile the
excitatory amino acids released may facilitate post-ischaemic injuryt66'2s4'44s or delayed
neuronal deat\f2r, other factors may in apparent contradiction protect against neuronal
deatlf2r.
The use of immunosuppressive interventions in animal ischaemic models have yielded
interesting results445;
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(l) Guilian and Robertson administered chloroquine and colchicine after inducing
ischaemic injury in rabbit spinal cords.r32 They observed a reduction in the number of
mononuclear phagocytes in the grey matter which was associated with improved hindlimb
and bladder function. It is thought that both these agents administered primarily led to the
inhibition of microglial proliferation.
(2) Cyclosporin A is capable of down regulating activated microglia .34s'44s Administration
in transient brain ishaemia leads to reduced neuronal and muscarinic receptor losses in the
gerbil hippocampus.'nn
(3) IL-lRA is believed to antagonise the actions of IL-lalphaand IL-lbeta. Relton et al
recently demonstrated that peripheral treatment with IL-IRA has a neuroprotective effect
in rat focal cerebral ischaemia.333' 
334 It has also recently been suggested that recombinant
IL-lRA has neuroprotective effects in experimental settings of excitotoxicity and trauma
rr 304
as well.
(4) Cycloheximide may possibly exert neuroprotective functions by inhibiting the synthesis
of proteins that promote cell death.356''nt The precise mechanisms remain unclear.'oo
3.9.5 Penetrating lesions
Stab lesions or freezing injuries of the brain lead to a large influx of haematogenous cells,
which subsequently contributeto alarge proportion of macrophages within the lesion.77'
r82' ree' 202'340'346'37t' oo' Some researchers maintain that macrophages are ONLY derived
66
from blood monocytestes and that the "resting branched microglia of Hortega" do not play
a significant roletne. This has not been particularly surprising in view of the extensive
vascular damage associated with these injuries.
However, the major deficiency of these studies has been the inabilþ to distinguish the
haematogenous macrophages from the other cells of microglial origin. This diffrculty is
higtrlighted by the ambiguous observations made in one such study by Gordana et alr28
who described the inflammatory cells around the stab wound as having "features of
amoeboid activated microglia and possibly originate from the blood stream, but a local
origin cannot be excluded". More recently, the resident microglial cells are also thought to
contribute significantly to the macrophagic pool in clearing the cellular debris.ar'277'317
However, the relative contributions of haematogenous/endogenous macrophages remain
unclear.
3.9.6 Demyelination
Multiple sclerosis (MS) is a multifocal disease with scarring plagues distributed within the
cerebral white matter and spinal cord."'It is further characterised by neurological
symptoms due to impaired nerve conduction.2n Clinical exacerbations are often followed
by temporary remissions although these become less frequent with progression of time.2a
In MS, it is believed that T-cell mediated activation of effector cells such as macrophages
lead to destruction of the myelin.2a'82'20e
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Experimental autoimmune encephalomyelitis (EAE) provides a useful animal model for the
study of multiple sclerosis in view of the comparable clinical manifestations and
pathological findings.2a'az,32e F.ÃT. can be induced in rodents and primates in 2 main
ways.'o' 
253 Firstly, active immunisation may be performed by subcutaneous or
intracutaneous innoculation of an encephalitogenic emulsion in the flank or foot pads of
animals. This may consist of whole spinal cord, purified myelin or specific myelin proteins
such as myelin basic protein or proteolipid protein with Freund's complete adjuvant and
V,tlled Mycobacterium tuberculosis. Alternatively, this can be achieved by passive transfer
of CD4* T-cells that have been derived from animals previously sensitised against CNS
antigens such as myelin basic protein.
pathologically, the perivascular lesions are characterised by both lymphocytes and
macrophages.'ot'"t It is postulated that macrophages may play various roles in the
pathogenesis of EAE. Initially, macrophages may release factors such as radical oxygen
species2ot which disrupt the basal lamina of the glia limitans'n. This may subsequently
promote further recruitment of lymphocytes from the peripheral circulation. During the
clinical phase, neuronal damage may result from various inflammatory mediators although
the exact mechanisms are still poorly understood. These include proteol¡ic enzymes,
radical oxygen species, NO, complement and cytokines such as tumour necrosis factor-
alpha.a6,re7,23e,264,3si Local TNF production, for example, can lead to a damaged blood
brain barrier, induction of adhesion molecules on the CNS vasculaturerss, direct damage to
myelin and oligodendrocytes3ss and induction of other inflammatory cytokines*'oto.




Depletion of macrophages prior to the onset of the clinical signs in EAE significantly
reduces both the clinicalaT' 
t78'r7e and pathological 
400 manifestations of the disease. Berger
et al further showed that disease severity is correlated with the absolute number of
macrophages invading the CNS parenchyma.'u Similar results have been obtained using
newer chemotherapeutic agents that inhibit macrophage activation.253
The resident microglial cells within the central nervous system are also thought to play an
important role in the immunopathology of EAEr23'2s6'4ts although this is less well studied.
Myelinophagic microglial cells appear at early stages in the disease process.'7t The
presence of microglial cells in demyelinating plaques suggest a phagocytic role although
they may have other roles such as antigen presentation andlor destruction of myelin and
oligodendroc¡es.277 Parenchymal microglial cells may upregulate the expression of MHC
class II antigens during EAE.r23'256'411 In both acute EAE and the first attack of chronic
relapsing EAE, activated microglial cells demonstrate phagocytosed myelin structures.22'
337 Interestingly, while this population of cells makes up 7 to l5% of immunocompetent
cells within the inflammatory infiltrates, the activated microglial cells appear to be more
effective in the removal of myelin debris then their haematogenous counterparts.33T This is
supported by in vitro studies demonstrating that cultured microglia appear to phagocytose
myelin more actively than peritoneal macrophages. However, while activated microglial
cells may share many macrophagic capabilities, the microglial cells do not appear to take




1. Macrophages in experimental rat syringomyelia are derived from the bone marrow
rather than resting microglia.
2. Macrophages that accumulate within the spinal cord parenchyma, subsequently
migratetowards the central canal ofthe spinal cord.
Aims
1. To establish rat radiation bone maffow chimeras.
2. To determine the origin of macrophages in a previously established rat model of
noncommunicating syringomyelia.





The current study was reviewed and approved by both the Animal Ethics Committee of
the Institute of Medical and Veterinary SciencelRoyal Adelaide Hospital @roject 79198)
and the Universþ of Adelaide @roject MJ7ll98).
L.2 Animals used
The Fl hybrids (DAXPVG/o) that served as bone marrow donors \ /ere generated in an
animal colony at IMVS under the direction of Professors G Mayrhofer and L Cleland
(Adelaide, South Australia). Adult DA (RT7.1) rats were supplied by the IMVS Animal
Breeding Facility (Glles Plains, South Australia) while PVG/c (RT7.2) rats used for the
initial cross-breeding purposes were acquired from the Animal Resource Centre @erth,
Western Australia).
L.3 Special facilities
RT7.1 DA rats that were irradiated were transported to the IMVS animal barrier room
(Frome Road, Adelaide) approximately one week prior to the commencement of the




about 6 weeks. A constant laminar air flow was maintained in the barrier room under






2 Generation of rat radiation bone marrow chimeras
2.1 Pilot Study
This was performed to ensure lhat rat radiation bone marrow chimeras could be
established successfully (FIGURE 4)
2.1.1Animals used
12 maleRTT.l DA rats (194-212 gms) were used in this initial experiment. These animals
had been reared in a pathogen-free environment and were transported to the IMVS barrier
room 4 days prior to the radiation treatment. Donor marro\ry was harvested from 2RT7.2
congeneic DA rats.
2. 1. 2 Antibiotic pr op hYlaxis
The antibiotic regimen was advised by the Dr Tim Kuchel, veterinarian, IMVS.
Accordingly, the rats received subcutaneous injections of gentamicin (Gentamicin 50,
RWR Veterinary Products Pty Ltd) twice daily commencing 4 days prior to the irradiation
date and continued for 10 days afterwards. The total daily gentamicin dosage was
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2. 1. 3 lrradiation protocol
A Philips Deep X Ray Unit (250 Kilovolts/l5 milli-amps) on free control, without added
filter was utilised (half value thickness of 0.7 mm of Copper) to administer the irradiation.
The dosage was calculated at approximately the mid point of the rat. A total of 10.00
Gray was administered over 10.51 minutes.
Each rat was transported from the barrier room to the Radiotherapy Unit at the Royal
Adelaide Hospital in individual standard perspex containers (dimensions l0x28x8 cm) on
the morning of the irradiation treatment. Each container had a glass lid with ventilation
holes which were subsequently overlaid and sealed with 2 layers of filter paper thus
preventing contamination of pathogens during transfer.
The 12 rats were irradiated in pairs in 6 consecutive treatment sessions. During each
treatment, 2 perspex boxes (housing 2 rats) were placed alongside each other within the
radiation field of 28x28 cm. The animals were promptly returned to the barrier room at the
completion of the radiation treatment.
2.1.4 Preparation of donor bone morrow
, tne ¡17.2 congeneic donor rats were anaesthetised prior to being euthanased with a
I
þ
lethal intra-p eritoneal inj ection of barbiturate.
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The long bones of the hind limbs were then dissected cleanly from the attached muscles
and soft tissues.The ends of the femurs and tibias were excised. Each bone was then
flushed with PBS/5YI fetal calf serum to remove the bone marrow. A cell suspension was
then created by repeated gentle aspiration and flushing through a 22 G syringe into a petri
dish. The suspension was then filtered through a ball of cotton wool to remove any bony
fragments. Subsequently, the test-tube was centrifuged at 1000 rpm (500G) for l0
minutes. The supernatant was discarded and the pellet re-suspended in fresh PBS/SYo fetal
calf serum solution to make up l0 ml of marrow cell suspension in all.
A manual cell count was finally performed under direct microscopy
2.1.5 Intravenous transfer of donor cells
Approximately 2 hours following the irradiation procedure, each irradiated RT7.1 DA rat
was anaethetised prior to injection of the cell suspension via the ventral tail vein. Each rat
received 0.8 mL of injected suspension (equivalent to I x 107 bone marro\il cells).
2.1.6 Subseqaent care
Upon recovery from anaesthesia, each animal was restored to its cage. The rats were
initially housed in individual cages but were subsequently housed in groups of 3 from Day
5. The rats \ryere carefully examined and weighed daily for 3 weeks. Detailed records were
maintained using standard post-irradiation IMVS AEC clinical record sheets. Thereafter,
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30 male RT7.1 pathogen-free DA rals (231-284 gms) were used in the main study. The
irradiation experiments were carried out on 2 separate days, involving 12 and 18 rats
respectively. A total of 10 donorP.TT.2 DA rats provided bone marrow for
transplantation. Each irradiated rat received bone marrow which had been harvested from
the long limbs of 3 donor rats.
2. 2. 2 Antibiotic prop hylncis
A change in antibiotic regimen was advised by Dr Tim Kuchel, veterinarian, IMVS. For 2
days prior to iradiation, soluble oxytetracycline (10 gmllitre,Tetravet 100) was
administered in drinking water. Subcutaneous injections of oxytetracycline (20 mgKg
body weight, TerramycinLlI,Pfrzer Animal Health) were subsequently performed on Day
I and Day 4 following the irradiation procedure. From Day 7, soluble oxytetracycline was
again administered in drinking water for a further 7 days'
2.2.3 Animal handling and transportation
New perspex containers with improved lids were used. These allowed for easier handling
and transportation. Each container was further divided into two equal halves by a plastic
separator, thus confining one rat to each compartment. This modification of the perspex
container minimised movement of the animals during the radiation treatment. The animals
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were irradiated in pairs over 6 and 9 consecutive treatment sessions respectively over 2
separate days.
2. 2.4 lrradiation protocol
The dosage of irradiation was re-defined and calculated at the exit point of the rat. This
ensured that the radiation administered to each rat did not exceed 1000 rads in any part of
the animal. Irradiation protocol details were otherwise as previously described (section
2.r.3).
2.2.5 Preparation und transfer of donor bone murrow
Bone marrow was harvested from 10 F.T7.2 donor rats and infused intravenously as
previously described. Each recipient in the initial group (12 rats) received 2 x 107 bone
maffo\il cells. The later group of l8 rats received 2.6 x 107 marrow cells each.
2.2.6 Subsequent care
Daily subcutaneous injection of sterile isotonic saline was performed (5 ml-s in each flank)
for a total of 4 days following the irradiation procedure. The animals were examined and
weighed daily for 3 weeks and weekly thereafter. Animals that became obviously unwell
were euthanased. Animals that experienced a weight loss of more than 20Yo of their
original weights in the first 5 days were closely scrutinised by the researcher in conjunction
with experienced animal care workers and the IMVS veterinarian.
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3 Intraparenchymal kaolin model of syringomyelia
3.1 Animals used
Thirty DA chimeric rats (6 weeks post-irradiation) were used @IGURE 5) Kaolin was
injected into the spinal cords of 30 rats. A needle puncture (injection without kaolin) was
performed in2 rats. The remaining 3 rats received no injection and were used as control
rats
Fifteen standard, non-irradiated RT7.1 DA rats were also used (FIGURE 6) Kaolin
injections were performed in 14 rats. One rat received an injection without kaolin.
3.2 Kaolin preparation
The kaolin suspension used for intra-parenchymal spinal cord injection was prepared by
adding 2.5 gms of non-autoclaved Georgia kaolin or hydrated aluminium silicate (Sigma
Chemical Corporation) to l0 ml.s of normal saline. The suspension was prepared freshly
each morning.
3.3 Kaolin iniection
Anaesthesia was induced by placing each rat in a perspex chamber that had been pre-
saturated with a mixture of 4Yo isoflurane and oxygen at2Litres/min. Each rat then
continued to self ventilate through a nose cone on a2.5Yo isoflurane/oxygen mixture.
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9 rats at 3 days 11 rats at 28 days
10 rats at 7 days
X'igure 5. Use of RT7.2 chimeric DA rats (3, 7 and 28 days indicate
sacrifice intervøls).








5 rats at 3 days E rats at 28 days
I peri-operative death
Figure 6. Use of commercially available RT7.I DA rats (3 and28 days
indicate s acrifice intervals).
Adequate depth of anaesthesia was assessed by performing the pedal withdrawal test at
the start of the procedure. During surgery, the depth of anaesthesia was monitored by
frequent assessments of inspiration depth and frequency.
The animal was supported across the thorax by a small soft drape roll. This produced a
gentle flexion of the cervical spine which made subsequent surgery easier.
Aseptic surgical technique was used throughout the operation. Having prepared the
shaved skin over the cervical region with betadine, the operative field was draped
appropriately. A vertical midJine skin incision of approximately 2 cm was performed to
end caudally just beyond the palpable vertebrae prominens. Having also incised the midline
raphe of the posterior cervical muscles, a relatively bloodless plane could be identified in
the midline. This allowed the para-spinal muscles to be dissected offthe C5 to C7 spinous
processes and lamina with relative ease. Dissection was extended to the level of Tl only if
deemed necessary during the operation. Upon adequate exposure of the laminae, a
laminectomy were performed at C6 to expose the dura overlying the spinal cord under
microscopic vision. Haemostasis was achieved without electro-cautery.
The stereotactic frame which had been mounted with a l0 pL Hamilton syringe with a 30
gavge point style 4 needle was then brought into the operative field. The needle tip of the
syringe was then localised over the ideal site (in the dorsal columns) and lowered onto the
dura without making any attempt to puncture it. A 29G needle on a 0.5 mL syringe (B-D,
Ultra-fine) was then used to cautiously puncture the dura and underlying arachnoid at this
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point. The needle of the Hamilton syringe was inserted to an approximate depth of 1 mm
into the spinal cord, with the bevel pointing laterally. 1.5 ¡rL of kaolin suspension was
gradually injected over 60 seconds while ensuring that there was no significant reflux into
the subarachnoid space.
The needle was finally removed and the stereotactic frame swr¡ng out of the operative
field. The wound was closed in 2 layers using 3/0 Vicryl sutures.
3.4 Post-operative care
Following the cessation of anaesthesia, each animal was left to recover while breathing
oxygen at2Litreslmin for approximately 2 minutes prior to restoring the animal into its
individual cage in the lateral position. Subcutaneous butorphanol tartrate (10 mglml
Dolorex, Intervet (Australia) Pty Ltd, Castle Hill, NSW) was administered for post-
operative analgesia.
3. 5 Post-operative review
Each animal was reviewed clinically on a daily basis for the initial 2 weeks following the
operation. Close attention was also paid to mobility and feeding behaviours of each
animal. Daily weighings were also carried out until they were sacrificed at the pre-
determined sacrifice time intervals or their pre-operative weights were restored.
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4 Tissue removal from the rats
Under deep anaesthesia (isofluorane), the old incisional wound was re-opened. The skin
incision was then extended linearly over the dorsal aspect of each rat to expose the whole
spinal column. Laminectomies were subsequently performed at all cervical and thoracic
levels to expose the spinal cord. When adequate exposure was obtained, the nerve roots
were cautiously divided bilaterally. Finally the spinal cord was transected distally and then
proximally at the base of the skull.
The animal was then immediately turned over and a laparotomy performed. The spleen
was dissected free from its mesenteric attachments and harvested.
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5 Tissue processing in developmental phase of study
5.1 Freeze Drying
Neural and splenic tissues were harvested as described previously (section 4). These
tissues were placed on a stainless steel tray (l0x1Oxl cm) and frozen by flotation of the
tray on liquid nitrogen. The tissues were then stored at -70 degrees Celsius until freeze
drying was performed.
The frozen tissue samples were placed inside the cavity of a sublimator (Modult, Edwards)
and maintained at -40 degrees Celsius throughout the freeze drying period. The cavþ
vaccuum was kept at <lO'2 mTorr for 3 days. The refrigeration was then switched offand
the chamber temperature allowed to equilibrate to ambient room temperature while still
under vacuum. The tissue samples were collected immediately following the release of
vacuum and embedded in parafün. The tissue specimens were immersed in paraffin wax
for 30 mins, I hour and 2 hours respectively under normal atmospheric pressure.
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5.2 ParaffTn sections
Paraffin sections were only used during the initial developmental phase of the project for
both histolo gy and immunohistocytochemistry.
5. 2. 1 Tissue preparation
The spleens from the two F.T7.2 donor DA rats (in the pilot study) were harvested and
fixed in 4%o paraformaldehyde for 5 days. The tissues were subsequently processed
through a series of graded alcohol to paraffin with xylene as a clearing agent. The blocks
were then embedded in paraffin wax. Six ¡rm tansverse sections were cut using a
microtome prior to mounting on glass slides.
5. 2. 2 Histology and immunoltistochemistry
Tissue sections were either stained with haematorylin and eosin in the standard manner or
prepared for immunostaining. Parafün sections destined for immunohistochemical studies
were first de-paraffinised and reþdrated. Immunostaining procedures were then carried
out using the method described in Section 6.1.3.1. The primary antibodies used were
directed against F.T7.2 (HIS4I) and EDl.
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6 Tissue processing in the main study
6.1 Fresh frozen sections
As immunohistochemical studies performed during the developmental phase of the study
demonstrated that the RT7.2 antigen was not stable to paraformaldehyde fixation, fresh
frozen sections were used for the main study.
6. 1. I Freezing techniques
Both the spinal cord and the splenic tissues were sectioned into longitudinal blocks each
measuring approximately l0 mm. Tissue segments were embedded in OCT contained in
l5xl5x5 mm disposable vinyl specimen molds (Tissue-Tek, Miles). Each mold was then
promptly immersed in a bath of octapentane precooled within a chamber of liquid
nitrogen.
The tissue/OCT blocks were then stored at -70 degrees Celsius until ready for use.
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6.1.2 Histology
Cryostat sections of 5prm thick were cut, mounted on slides and air-dried. Sections for
light microscopy were stained with haematoxylin and eosin in the standard manner.
6. 1. 3 Immuno hßto ch emßtry
6.1.3.1 Immunoperoxidase staining procedure
Tissue sections destined for immunostaining were fixed in acetone for l0 minutes and air-
dried overnight. Primary antibodies EDI and HIS4I were obtained from Serotec (Oxford,
UK). The secondary species-specific peroxidase linked anti-mouse immunoglobulin was
from Amersham International (Buckinghamshire, England). Normal rat serum (10%) was
added to all antibodies to minimise non-specific staining.
Slides were initially re-hydrated in PBS after wax circling the tissue sections with a PAP
PEN (Zymed, San Francisco, CA USAO. These were then exposed to 3Yo hydrogen
peroxideÆBS for 5 minutes. The tissue sections were then washed in PBS and incubated


















Table 2. Antibodies used for immunohistochemistry
After two further washes in PBS, the secondary antibody was applied at a dilution of l/25
and incubated for a further I hour, prior to visualisation with nickel 3,3'-diamino-
benzidine (DAB).
6.1.2.I Indirect Immunofl uorescent Staining
Cryostat sections of 5 ¡rm stored at -70 degrees Celsius were thawed. They were then
fixed in acetone for l0 minutes and allowed to air dry overnight.
Slides were initially re-hydrated in PBS after wax circling the tissue sections with a PAP
PEN (Zymed, San Francisco, CA" USAO. These were then exposed to 3Yo hydrogen
peroxide/PBS for 5 minutes. The tissue sections were first incubated for I hour with EDI
(dilution 11400) (Serotec). The slides were then washed twice in PBS after which they
were incubated with the secondary donkey anti-mouse-specific-Texas Red (dilution 1/100)
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(Rockland Laboratories, US) for another hour. Following2 further washes, the sections
were exposedto 5Tyo normal mouse serum for 30 minutes to block the free valencies
present on the secondary antibodies previously applied. Finally, the second primary
antibody HIS (directly conjugated to FITC) (dilution 1/50 in 50olo normal mouse serum)
(Serotec, UK) was added and incubated for another hour. After 3 final washes in PBS, the
slides were mounted using'antifade' aqueous mountant solution.
6.1.2.2 Assay of chimerism
The spleens of all chimeric rats were removed at the time of sacrifice and stored at -70
degrees Celsius. Chimerism \ryas assessed by examining splenic tissue sections derived
from 3 randomly selected chimeric rats. Immunostaining was performed using monoclonal
antibody HIS4I against FiT7.2.In the chimeras, the transplanted cells were RT7.2*
whereas the host cells were RT7.2'.
6.1.2.3 Counting of immunoreactive cells
6.1.2.3.1 Spinal cord tíssues
The distribution of immunoreactive cells within the parenchyma of the spinal cord was
carefully studied. Typically, the kaolin droplet was visible to the naked eye on 3 to 4
transverse sections. A representative slide was chosen in which the cross sectional area of
the kaolin droplet was the largest. Manual counts of EDI and HIS41 positive cells were
then performed on separate but nickel DAB- stained sections at the same level of chimeric
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rats. This proved to be reliable on comparison with the doubleJabelling
immunofluorescence studies.
In the 3-day group, evaluation was performed directly on the inimunofluorescence slides.
This was because there was a relatively small but nonetheless significant component of
RT7.2* but EDI- cells which represented a combination of neutrophils and lymphocytes.
Counts performed on the nickel DAB stained sections would have led to an
overestimation of RT7 .2*,F;DI* cells. Manual counts of EDI positive cells in tissue
sections from non-chimeric rats were performed only on Nickel DAB sections.
Two methods of manual counting were used. Firstly, the total number of EDI+ cells
within the entire selected spinal cord section was evaluated. Secondly, cell counts were
perfiormed within a fixed area atthe edge of the kaolin lesion under high magnification
(100Xs). This was achieved by using an objective microscopic eyepiece which had been
pre-embedded with a small grid in the centre of the visual field. At least 3 different areas
were counted in each case and an average derived'
6. 1.2. 3. 2 Splenìc tíssues
The RT7.2 immunostaining patterns in splenic tissue sections were carefully studied. Cell
counts of immunoreactive cells in both myeloid and lymphoid regions were performed




Statistical comparisons of cell counts between chimeric and non-chimeric rats were
performed using 2-tatled Student t-tests (p<0.05). Calculations were performed using
Microsoft Excel Software.
6.1.2.5 Photography
Conventional photomicrographs were taken using a Nikon F60l camera mounted on a
BX50 Olympus microscope. The film used for conventional photography was Kodak
Ektachrome EPY 135-36.
Immunofluorescence analysis of tissue sections was performed using an Olympus BX50
fluorescent microscope. Immunofluorescence photography was carried out using a digital
camera (Sony, SSC-M370CE B&\¡ú CCD) set up which was attached to a 7600/200
power Macintosh computer. The software utilised was NIH Image vl.60b7. Images (Gtey
scale) were viewed in real time and captured as TIFF files. For illustrations in the current
thesis, the pictures were colourised using Adobe photoshop, Version 5.0 Software to





6.2 Flow Cytometric Analysis
Flow cytometry on peripheral blood was performed only during the pilot study. The nine
surviving rats in the pilot study were tested at 3 weeks post-irradiation/bone marrow
transplantation.to confirm that successful chimerism was being established with the
existing study protocol.
6.2.1 Collection of blood specimens
Under anaesthesia, 400 pL of blood was collected from the ventral tail vein of each of the
9 rats using a heparinised 23G needle and temporarily stored in plastic containers
containing EDTA. Blood was also collected from RT7.2 non-irradiated DA rats and
RT7.1 DA rats. These served as both positive and negative controls respectively.
6.2.2 Indirect labelling of cells with monoclonal øntibodies
All labelling steps were performed at 4"C. Fifty pL of primary antibody (either HIS4I or
OX4l(control)) contairung l}Yo (v/v) heat inactivated NRS was added to 100 ¡rL of
whole blood in each FACS tube (Falcon, Becton Dickson Labware, New Jersey, USA
Cat. No. 2008). The cells were then incubated on ice for I hour. Following this
incubation, the cells were washed twice with immunoflorescence buffer (lL PBS, 20 mI
FCS, 10 mL lM Azide) and resuspended in 50 ¡rL of FlTC-conjugated secondary
antibody (l/50 dilution, FITC conjugated goat anti-mouse polyclonal Ig in l}Yo NRS).
After a further incubation of t hour, the cells were then washed again with IF buffer. The









ï 6.2.3 Flow cytometrY
Labelled cells were analysed using a FACSan (Becton Dickinson, San Jose, California)
equipped with CellQuest software (versions 1.2 and 3.1f). Fluorescence and forward light
scatter (FLS) profiles were accumulated from I x 105 cells. The proportion of cells
specifically labelled was estimated as those with fluorescence intensþ greater than 98olo of










Flow cytometry studies were only performed in the initial pilot study. Tests performed at 3
weeks post irradiation/marrow transplantation showed that RT7.llRTT.Z chimerism was
successfully established in all nine surviving study rats in the pilot study. The results of













Table 3. FIow cytometric resaltsfrom testing of peripheral blood in pilot study.
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2 Outcome in establishing rat radiation chimeras
2.1 Pilot study
One rat was euthanased on Day 5 as it appeared clinically unwell. Two other rats \ryere
subsequently found dead on Day 6 post-irradiation.
Autopsies on the th¡ee deceased rats were performed by Dr J W Finnie, Veterinary
Pathologist, Veterinary Services Division, IMVS. The salient pathological findings were
those of radiation-induced bone marrow depression and gastro-intestinal haemorrhage.
All the other nine surviving rats sustained a weight loss of l5-20yo over the first 5 days.
While most of the rats displayed ruffled fur and showed evidence of reduced drinking and
eating during this time, all of them remained reasonably active. They began to regain their
weights after Day 6 and the majority of animals were near to or had surpassed their initial
weights at two weeks.
2.2 lÑ{ain study
The rats were irradiated in groups of 12 and l8 respectively on separate days.
In the first group of 12 animals, there u/ere no deaths. All rats were mildly dehydrated for
several days post-irradiation but remained well and active.
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In the second group of 18 animals, 3 rats were euthanased between Days 4-6 becat¡se they
were clinically unwell. One rat was found dead in the cage. Thus the overall mortality was
l3%. Asimilar pattern of initial weight loss and subsequent gain in the second week was
observed. Similarly, the surviving rats remained active throughout the period of
observation.
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3 Developmental issues in tissue processing
3.1 Freeze drying
This technique of tissue processing was not utilised in the main study. The limited
preliminary results obtained during the developmental phase of the study showed that the
parafün wax did not penetrate the tissue blocks adequately. Beyond the most superficial 3-
4 mm, the internal architectural structure of the tissues (both spleen and spinal cord) was
severely disrupted when the cut surface of the tissue block was examined under a l0xs
magnification dissecting microscope. It was also not possible to cut tissue sections using
the microtome in the conventional manner.
3.2 Probtems encountered in initial immunostaining testing of HIS4L
Initial immunological testing was performed on parafEn sections of splenic tissues of
R.T7.2 DA rats in accordance with recommendations of the antibody supplier (Serotec).
Immunostaining using HIS4I(neat) revealed only minimal patchy staining of clumps of
nucleated cells.
Parallel testing on paraffin sections of spleen was also carried out using a sample of HIS
4l (purified antibody at 0.5 mgl 0.5mL) from a different manufacturer (Pharmingen).




One non-chimeric rat died from anaesthetic related problems. It suffered a cardio-
pulmonary arrest at the end of the surgical procedure. The autopsy of the animal did not
reveal any surgical complications. No neurological sequelae were observed in all other rats
that underwent surgery.
4.2 Exclusion of tissues from analysis
The crucial tissue blocks of spinal cord in a RT7.I DA rat suffered severe fractures during
the freezing process, thus precluding any further tissue anaysis. Cell counts were not
performed in one chimeric DA rat because the volume of kaolin injected was clearly
disproportionately small and deemed insufücient. This was attributed to mechanical
problems with the Hamilton syringe/needle encountered during the operative procedure in
this particular rat. The tissues derived from the rat that died peri-operatively were also
excluded from the study.
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4.2 Histology
4.2.1 Control cltimeric rats
Each cervical spinal cord contained a short segment of central canal in which a small ovoid
or slit like lumen could be identified readily. Exending caudally beyond this segment, the
central canal was collapsed without a distinct lumen. The ependymal epithelium mostly
consisted of 2layers of cells in close apposition (FIGLIRE 7). In some sections, the
ependymal epithelium was folded.
4.2.2 Kaolin injections in chimeric rats
4.2.2.1Central canal
At 3 days following the intraparenchymal injection of kaolin, subtle abnormalities of the
central canal were observed. These changes i4cluded distortions of the ependymal
epithelium and alteration of the shape of the central canal. However, none of the central
canals appeared to be abnormally enlarged.
Dilated segments of the central canal were seen at one week and 4 weeks following the
intra-parenchymal kaolin injection (FIGURE 8). Although this typically occurred rostral to
the site of injection, the dilated canal occasionally extended caudally past the point of
kaolin injection. The location and length of the syrinx was variable and unpredictable.
Synechiae and occasional cells were seen within the central canal.
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At 4 weeks, the enlarged central canal was occluded by large aggregates of kaolin
particleJaden macrophages in some animals (FIGURE 9). This reached massive
proportions at some segments and extended over many segments of the spinal cord. In the
other animals, such a macrophagic inflammatory infiltrate was not observed within the
central canals oftheir spinal cords.
Massive central canal distension was not observed in any of the animals str¡died
l0l
tr'þure 7. Phatomicrograph of trønsverse spinal cord
section demonstrating the appearance of a normal central
canal at C6 in a control chimeric rat. H&8, X50.
;
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Figure 8. Photomicrograph of a transverse spinal cord section
from a chimeric rat sacrifrced at I weekfollowing kaolin
injecrton. The central canal is significanþ dilated. H&8, x100.
X'igure 9. Photomicrograph of a transverse spinal cord section
from a rat sacrifi.ced at 4 weelæ. The central canal has been
totally occluded by kaolin-laden macrophages (aruow). H&8,
xL00.
4.2.2.2 Site of injection
At the level of injection, the kaolin droplet was readily detected in the dorsal columns and
the central grey matter of the spinal cord (FIGURE l0). This was visible to the naked eye
and typically occupied 3 to  levels (each 250pm apart) of tissue sections. At 3 days, an
inflammatory infiltrate could be seen on the edge of the kaolin lesion. By I week, a
relatively mature granuloma had formed with a distinct wall of mononuclear cells. At 4
weeks, extensive mononuclear migration had occurred into the kaolin droplet. Free kaolin
was no longer observed.
4.3 Immunohistochemistry in spinal cord tissues of chimeric rats
4.3.1 EDl
4.3.1.1 Morphological features
Immunostaining of EDl yielded an intense cytoplasmic staining pattern within the majority
of immunoreactive cells (FIGURE 1l). Although cytoplasmic membrane staining was not
evident with routine dye (nickel DAB) technique, this was visualised under
immunofluorescence (FIGURE 1 2).
The morphological appearances ofEDl* cells were varied. The immunoreactive cells fell
into 2broad categories. Firstly, large, round (or ovoid) cells with foamy cytoplasm
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Figure 10. Photomicrograph of transverse spinal cord
section at the level of C6. The kaolin droplet has been
injected into the dorsal columns and the central grey motter






Figure lLa. Photomicrograph of RT7.2 positive cells within the
l<aolin droplet at I week. The cytoplasmic membrane

















Figure llb. Photomicrograph of EDl+ cells on the edge of the
I<nolin droplet on a rat sacrificed at I week. The larger cells with
intense cytoplasmic staining (yellow arrow) are contrasted with
smaller cells more distantfrom the lesion (green aruow). Nickel
DAB, x100.
f igure 12. Immunofluorescence patterus of RT7.2 and EDI
antigens. The typical cytoplasmic membrane staining pattern
of RT7.2+ cells is well seen in (A).FITC, XIÛ}.This is
contrasted with the mare intense, cytoplasmic staining in
EDI* cells in (B). Texas Red, X100.
resembling classical macrophages could be identified. These were easily distinguished from
other smaller, microglialJike cells with denser staining cytoplasm and processes which
were scattered within the spinal cord parenchyma. However, many cells displayed
intermediate morphological features and these could not be readily classified into either of
the above categories.
4.3.1.2 Pattern of immunoreactivity
Large numbers of EDI immunoreactive cells were seen within the spinal cord parenchyma
at the level of the kaolin injection even at Day 3. Many large cells with intense cytoplasmic
staining had accumulated around the kaolin droplet. These cells were also seen along the
needle track extending from the pia into the kaolin lesion. Away from the kaolin lesion,
progressively fewer immunoreactive cells were observed in the parenchyma. The
immunoreactive cells located furthest away from the kaolin droplet were typically small
and thin cells with occasional cytoplasmic processes.
The extent of inflammation was most marked at 1 week (FIGURE 13). A dense rim of
EDl*cells had walled offthe kaolin droplet. In some rats, the EDI* cells appeared to
extend centripetally inwards (toward the central canal) within the cord parenchyma. The
majority of these cells (towards the central canal) were of the smaller, microglial-like cell
type.








Figure 13 . Photomicrographs of spinal cord sections {rom a chimeric
rat sacrificed at I weekfollowing the kaolin injection. (A): Transverse
section at C6 demonstrartng the 'walling' effect of RT7.2 positive cells
around the l<nolin droplet. Note the absence of immunoreacrtve cells
within the parenchyma away from the l<nolin droplet (B): Transverse
section showing the more florid response of EDI positive cells,
particularþ in the parenchyma of the spinal cord (yellow arrow). In
addition, the centripetal pattern of EDI immunoreactivity towards the





Firstly, the kaolin droplet was totally engulfed by ED1 positive cells although the staining
intensity of each cell had diminished quite markedly in comparison with previous time
intervals (FIGURE 14). Around the granuloma, there was an obvious rim of strongly
positive cells which had the morphological features suggestive of classical macrophages
(large, round with foamy cytoplasm). Beyond this, a large number of progressively smaller
EDI positive cells with intermediate morphological features were seen scattered
throughout the cord parenchyma. These cells extended rostrally and caudally for multiple
levels beyond the lesional site (FIGURE l5).
Secondly, in some animals, the enlarged central canal was totally occluded by an extensive
accumulation of large, round EDl positive cells. These cells also exhibited less marked
staining intensity.
Lastly, it was observed that away from the kaolin injection site the EDI positive cells
appeared to be preferentially located within the white matter of the spinal cord @IGURE
16). This is particularly evident in some tissue sections (both rostral and caudal to the
kaolin droplet) where these immunoreactive cells were only confined to the white matter

















X'igure 14 . Photomicrographs of spinal cord sections from a
chimeric rat sacrificed at 4 weeks.Nickel DAB, X50 (A) The
l<nolin droplet has been engulfud largely by bone murrow-
derived (RT7.2+) cells (B) The intlammatory infiltrate of EDI+
¡s extensive and not confined to the l<nolin droplet. EDI+ cells
within the l<aolin droplet stain much less intensely than those
cells at the boundary of the lesion. This probably reflects the
cytotoxic effects of kaolin particles on mocrophages. Cells









Figure IS' sehetnatic represenl€ttian af trwævers e spì.nøl,eotd s,ec tìons
sørçladfutn dffirent levels fu ø røt sacrifi,ced at 4 weeks, EDI+ ,e:etls are







, Macrophages fiaemato gnoudinicrogllaf' Artivatedmtcroglia
f igure 16. Schemartc representation of transverse spinal cord tissue
secrtons at level of l<aolin dropletfrom rats of varying survival times.
Microglial activation occurs early and becomes progressively mare
marked. Haematogenous mocrophages migrate primarily towards the
I<nolin droplet. In some animals, the haematogenous macrophages were
also seen within the dilated central canal at 28 days.
4.3.2 RT7.2
4.3.2.L Morphological features
In contrast to EDl, the RT7.2 allele of CD45 yielded a distinct membrane staining pattern
(FIGURES 11 and l2). The majority of immunoreactive cells appeared to share
morphological features with the large round EDI positive cells described above.
4.3.2.2 Pattern of immunoreactivity
¡g17.2* cells progressively accumulated as a visible rim around the kaolin droplet (3 days
and I week) (FIGURE l3). Some immunoreactive cells could be seen perivascularþ
within the parenchyma of the spinal cord. These perivascular cells appeared
morphologically distinct (FIGURE l7). Typically they were smaller, thinner and appeared
to stain more intensely. The FJT7.2* cells were not observed within the kaolin droplet at 3
days. However, by 4 weeks, these cells could onlybe found within the kaolin droplet
accounting for the large majority of cells within the granuloma.
4.3.3 Co-localisation ol EDI and RT7.2
4.3.3.1 Pattern of immunoreactivity
The double-labelling immunofluorescence studies allowed cells which were RT7.2*, EDI*
to be easily identified (FIGURE l8). These antigens appeared to be co-localised on the
large majority of cells that had accumulated around and within the kaolin droplet
(FIGURE 19). At 4 weeks, most of the EDI*cells found within the granuloma were also
ll4
F':T7.2* (FIGURE 20). Hence, the bone marrow-derived macrophages were therefore
largely responsible for the granuloma formation. In addition the macrophages within the
syrinxes seen at 4 weeks were also doubly labelled (EDI+,RT7.2+).
In contrast, the RT7.2-,ED1* cells of presumed microglial origin accounted for the other
immunoreactive cells observed within the parenchyma of the spinal cord. These cells
extended to the boundary of the kaolin granuloma. Certainly, these particular cells near the
kaolin-cord interface could not be distinguished from their haematogenous counterparts
on morphological features alone and without the aid of immunohistochemistry (FIGURE
2r).
Notably at 3 days, a small but significant number of RT7.2+ED1- cells was present within
the inflammatory infiltrate. These are most likely to represent neutrophils (or lymphocytes)
which form a part of the earþ inflammatory response. They were rarely observed beyond
this time interval.
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Figure 17. Photomicrographs of
perivascular cells in a chimeric
rat sacrificed at 4 weeks. (A) AU
the perivasular cells are derived
from haematogenous (RT7.2+) in
origin. FITC, X100. (B) These
cells also express the EDI
antigen intensely. Texas Red,
X100. (C) A mixture of activated
microglia and other
haemntogenous cell types (such
as neutrophils and lymphocytes)
may be seen nearby. FITC,
Texas Red, X100.
X'igure 18 . Immunostaining features of doublyJabelled cells.
X100. The co-localisation of EDI (Texas Red) and RT7.2
(FITC) yields an orange colour on immunofluorescence.
Some cells also exhibit a greenish-yellow 'halo' effect, as
illustrated here. This is not as easily perceived at low
magnification.
Figure 19. Photomicrographs of spinal cord sections in a
chimeric rat sacrified at I week. (A) Significant
accumulation of EDl+ cells within the surrounding
parenchyma around the l<aolin droplet, Texas Red, x 25. (B)
The majority of the mncrophages migrating into the køolin
droplet are bone marrow-derived (co-localisation of EDI
and RT7.2 antigens). FITC and Texas Red, x50.
tr'igure 20. Photomic ro graphs
of spinal cord sections in a
chimeric rat sacrificed at 4
weeks, X50. (A) Large
numbers of EDI* cells are seen
both within the l<aolin droplet
and the sunounding
parenchymn. Texas Red (B)
RT7.2+ cells derivedfrom the
bone marrow are confined to
the vicinity of the kaolin
droplet. FITC. (C)
H aemato g e nous mac rophøg e s
(RT7.2+ ) demonstrate an
ffinity for the kaolin droplet
whil e mi c ro gli al- de riv e d
macrophages (RT7.2 are
largely seen in the surrounding
spinal cord parenchyma.
Figure 21. Photomicrograph of transverse spinal cord
secrtons in a chimeric rat sacrificed at 4 weeks. (A) h is not
possible to distinguish the origin of EDl* mncrophages
based on morphological features alone. Texas Red, X100. (B)
Co-labelling of the RT7.2 antigen (arrow) by using the
manoclonal anrtbody HIS4I allows this dffirentiation to be
mnde with relative ease. FITC, Texas Red, X100.
Counts of ED1* and RT7.2* cells on sections of transverse spinal cord sections sampled at
the level of the kaolin droplet are listed in Table 4. Proportions of EDI*/Rl7.2* and





4 weeksl week3 days
Table 4. Counts of EDI* and RT7.2* cells at sacrifice intervals of 3 days, I week qnd 4
weeks.
4.4 Immunohistochemistry in spleens of chimeric rats
The spleens of 3 chimeric rats were examined. More thang3Yo visualised mononuclear
cells stained positively for RT7.2 in all sections examined (FIGURE 22). The endothelial
cells, vessel wall, connective tissue and capsule, all of which are of host origin remained
unstained.
4.5 Histology and immunohistochemistry in RT7.1 DA rats



















Table 5. EDI+ cells of microglial ßn2') and bone mnrrow (RT7.2+) origin
in chimeric rats sacrifrced at 3 days, 7 days and 28 dnys. Cell counts were
perforrned on transverse spinal cord tissue sections, in which the cross-
sectional area of the kaolin droplet was the largest.
Figure 22. Photomicrograph of splenic tissue sectionfroma
chimeric rat sacriftced at 6 weelcs post-irradiation and bone
marrow transplanation. The spleen has almost been
comple tely re - consrttute d by RT7.2+ lymphoid and nry e loid
cells. Nickel DAB, x50.
kaolin injections. At both time intervals, the histological appearances \¡/ere identical to
those observed in chimeric rats sacrificed at the same survival intervals. Immunostaining of
spinal cord sections'was only performed with the antibody against EDl. Similarly, no
differences in the distribution and pattern ofEDl* cells were observed.
The extent of macrophagic inflammation, as represented by counts of EDI* cells in non-




1 Rat radiation chimeras
1. 1 Historical perspective
In 1951, Jacobson and his colleaguesrt'discovered that the implantation of autologous
spleen could prevent the death of mice which had been lethally irradiated. Lorer:ø et al2a2
reported in the same year that the administration of isologous bone marrow had a similar
protective effect. Subsequently it became clear that the injected bone marrow cells acted
as a transplant or graftee'z3o'4222 repopulating both haematopoietic as well as lymphoid
tissues. These \ryere named radiation chimeras.
1.2 Relevance to current studY
At present, there is no histological feature or cellular marker that reliably distinguishes
microglia-derived macrophages from those that have been derived from the bone malrow.
In an attempt to circumvent this problem, a number of experimental techniques have been
tried.
In the past, autoradiography was most commonly used for this purpose. In this technique,
cells in the S phase are labelled following a single pulse of fFilthymidine. If a short
survival time (e.g. less than t hour) is used, only the locally dividing cells will be labelled
in the tissue section. However, if the survival time is longer e.g.24 hours, there will also
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be a contribution of labelled cells from the circulation.tt'In general, the deficiencies of
autoradiographic studies have been clearþ highlighted by Matsumoto and Fujiwara.257 The
use of DNA-binding radioactive agents to label a highly proliferative cell population
implies that the level of radioactivity may diminish after a number of cellular divisions.
Subsequently, the possibility of unlabelled blood-derived cells in the CNS cannot be
excluded. Furthermore, this technique has also been criticised due to the technical
difficulty and consequent interpretation variations.
Other potentially helpful experimental techniques such as carbon labelling of peripheral
monocytes are only suitable for studies with short sacrifice times.233'"0 The current study
required animal survival times of up to 4 weeks. This would have introduced the
possibility of carbon being re-utilised or ingested by other macrophages, as the original
macrophages die.
The concept of rat radiation bone marrow chimeras provides an elegant method of
unequivocally identifying macrophages of bone marrow origin in the current experimental
model of noncommunicating syringomyelia. Recentl¡ this technique has also been used
extensively to study the role of macrophages/microglia in the setting of EAE'168'2tt'257
In the current study, commercially available RT7.l Dark Agouti rats were irradiated to
ablatetheir native bone marrow. They were then transplanted with bone marrow
previously harvested from RT7.2 congeneic DA rats. The animals were then allowed to
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mature over 6 weeks as the haematogenous cells repopulated the somatic tissues. It is
known that this process is complete by 6 weeks from previous studies.257
1.3 Technical aspects
The mortality of animals in the pilot study was 25Yo (3 of 12 animals). A number of
modifications were subsequently made to the experimental protocol for the main study
These included.
(l) subcutaneous supplementation of normal saline on the first 4 post-irradiation days as
recommended by Dr Tim Kuchel, veterinarian, IMVS.
(2) prescribing the maximal dose of irradiation (1000 rads) at the exit point of the animal's
body on the ventral asPect
(3) doubling the quantity of bone marÏow infused into the recipients
This resulted in a mortality rate of 13 Yo inthe main study (4 of 30 animals). While it is not
possible to draw any firm conclusions from the comparison of these results, the increased
quantity of bone maffow transplanted was most likely to have imparted the greatest
protective benefit.
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While death after whole-body exposure to doses injurious to haematopoietic and
gastrointestinal tissues is often thought to be caused by infectiona, gastro-intestinal
haemorrhage was the predominant cause of death in our group of animals, as defined at
autopsy.
Our results are comparable to the experience of Mayrhofer who obtained a mortality rate
of approxim ately lOYo using a similar study protocol258. In contrast, Hickey and colleagues
reported no mortalþ and minimal morbidity (no evidence of bleeding diathesis) in their
series of DA radiation chimerasrTr. They administered l0 Gy over 5 minutes, resulting in a
significantly higher dosage rate. The reasons for these differences are not entirely clear.
One possible explanation may be that Hickey and his colleagues administered significantly
more donor marrow cells (lxl0t¡ into each recipient animal. Clearly, further research is
required to clarify this.
The variability of survival outcomes following lethal irradiation (even with bone marrow
rescue) has long been noted by other researchers.Loret:.ø et al injected homologous bone
ma1aow into lethally inadiated mice. While this offered "excellent protection", the 2l'day
mortality figures in different study groups ranged from 0 to 32Yo.243 Typically, when
mortality occurs in mice, it occurs within 7-10 days when the haematopoietic depression is
most marked.2a3 All deaths in the current study occurred within the first week.
Furthermore, there is also inter-species variation in terms of both radiation susceptibility
and requirements for a bone marrow "rescue".150'243'4o7 The mean lethal radiation dose
j
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@Dso) varies from 3.7 Gy in dogs to 7 .75 Gy in the rat 
r50. In contrast, the LDso for
humans is thought to be approximately 4 Gy.r50
The optimal dosage for ensuring ablation of the bone marrow while minimising mortality is
difficult to establish. The differences in the X-ray machines utilised and precise
prescription of treatment may potentially result in variations of the dosage administered.
These details are often not stated in previously published studies. While these variations
are usually considered to be minor, they may theoretically become significant if they fall
onto the steep part of the dose-mortality curve. Previous studies have utilised radiation
doses of between 900-1000 rads depending on the source of radiation (deep X-rays or
garnrîarays from a cobalt source) with varying dosage rates.2e' 
168' 170' 2tt'2r3' "t \ryhile it
would be expected that the mortality rate would be reduced with a reduction of the
radiation dose, this would compromise the aims of the current study as a result of
incomplete ablation of the native bone marrow due to incomplete chimerism.
1.4 RT7 allellic system
The RT7 antigen is polymorphic and expressed as a diallelic system, either as RT7.l or
RT7.2.244 The RT7.l strain of rats include LEW, COP, DA BN, F344, M520 and WF/fz
while the RT7.2 strain includes WF, BUF, NBR and BH.2s The HIS4l antibody reacts
specifically with CD45 (Leukocyte Common Antigen) expressed on both myeloid and







CD45 is a member of the Protein Tyrosine Phosphatase (PTP) family. It is a heavily
glycosylated glycoprotein with an Mr 180,000 to 240,000.15' r88 The extracellular domain
of CD45 varies between 391 and 552 amino acids long with I l-16 N-linked carbohydrate
attachment sites.rt't88 It is highly variable as a result of alternative splicing of exons 4,5,
and 6 and differing levels of glycosylation. The cytoplasmic domain contains 700 amino
acids, with two PTP catalytic domains. The CD45 isoforms are believed to play complex
roles in T-cell and B-cell antigen receptor signal transduction.
1.5 Assay of chímerßm
The optimal way of assessing the extent of chimerism in radiation chimeras is unclear. In
the initial pilot study, it was necessary to verify that chimerism had been established in the
DA rats. Flow cytometric studies performed on peripheral blood was a relatively simple
technique that allowed such an aim to be realised. The detection of RT7.2 haematogenous
cells in the peripheral blood of all nine rats in the pilot study confirmed that chimerism had
been successfully achieved. However, the wide variability of flow cytometric results was
somewhat surprising. One probable explanation is that the cytometric studies were
performed at 3 weeks, prior to the establishment of stable chimerism. This process is
known to be complete only after 4 weeks in rats.257
Another difüculty encountered is the interpretation of the test results. Currently, there are





blood with those derived from somatic tissues such as spleen and lymph nodes. Hence the
most accurate or'ideal'method of assaying chimerism is not known. Recent studies using
radiation chimeras have assessed the extent of chimerism by the analysis of cellular
populations in somatic tissues such as the spleen.l6s' 
l6e' 110'177'212'213' 2s7 This approach was
therefore adopted in the current study.
2 Developmental issues
2.I lnittal immunohistochemistry testing
The initial testing of HIS41 was hampered by the supply of a defective product from the
manufacturer. Subsequently, difficulties were also encountered in establishing successful
,l immunostainng on parffin sections of RT7.2* rat splenic tissues in accordance with the
'!T
,' -un rfacturer's data sheets. No significant immunostaining was observed in these tissue
secüons.
Personal communications with the clone originators, Drs J Kampinga (Quadrant Research
Foundation, Cambridge Research Laboratories) as well as FGM Koese (Department of
Histology and Cell Biology, University of Groningen) confirmed that they had not
performed any immunological work on formaldehyde-fixed, paraffin-embedded tissues
previously. Independent testing of HIS4I was requested and kindly performed
concurrently by Pharmingen laboratories (USA) Their results confirmed that only






As it became evident that the F.T7.2 antigen was unstable to formaldehyde fixation (in
contradiction to the manufacturer's initial claims), it was concluded that the application of
HIS4l on paraffn sections did not constitute a sufficiently reliable and reproducible basis
for use in the main study. Hence fresh frozen tissues were utilised in the main study.
2.2 ß reeze-drying tissue processing
The technique of freeze-drying tissues possesses theoretical benefits of optimising antigen
preservation while maintaining superior morphological detail. The possibilþ of utilising
this technique \¡/as initially explored in view of these perceived advantages. Unfortunately,
the initial results were disappointing. The main difficulties encountered were largely due to
the lack of suitable equipment (e.g. sublimator, vacuuum \¡/ax embedder etc).
Initial freeze-drying tests were performed using a sublimator which served the food
processing unit at RAH. As this was shared equipment, it was not practical to perform
multiple tests due to the long duration of freeze drying required by the freeze-drying
process (up to 7 days). On each occasion of testing, the machine could not be used for its
original intended purposes.
Consequently, it was felt that a much longer time frame (at least several months) was
required for optimising various aspects of the freeze drying methodology. This was not
considered to be feasible in the current study.
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2.3 Modification to operative technique
In previous departmental studies, the kaolin injections were performed using a manually
sharpened 30 gauge needle which was attached to a Hamilton syringe. Despite cautious
sharpening, the needle point invariably deformed the dura and the underlying spinal cord
to a significant extent prior to penetration. On occasions, several attempts were required
to achieve penetration of the cord tissue. This was deemed unsatisfactory in the current
study. This problem was overcome by the initial use of a commercially available 29G
tuberculir/insulin syringe which was sufficiently sharp to pierce the dura and underlying
arachnoid with minimal cord indentation. The kaolin suspension was then injected using
the Hamilton syringe and needle with ease.
3 Results of the current research
3.1 Histological fTndings
The histological features in the current model of rat syringomyelia at the light microscopy
level have already been extensively studied in Sprague Dawley rats.267' "t Similar findings
have been reproduced in the current study using Dark Agouti rats with several notable
differences.
Firstly, in contrast to results reported by Milhorat and colleagoes'u', massive dilation of
the central canal was not observed in the current study. Secondly, in some rats (both
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chimeric and non-chimeric) sacrificed at 4 weeks, the syrinx appeared to be totally
occluded by macrophages over multiple spinal cord levels. While Stoodley et aP75
reported similar observations of macrophages within the central canal in rats 6 weeks after
kaolin injection, these were apparently quite localised. The reasons for these differences
are unclear. However, it is possible that the different strain of rats may account for some
of the observed differences. DA rats were selected for the current study because of the
availability of a congeneic RT7.2 strain which allowed the production of radiation bone
marrow chimeras.
3.2 Origin of macrophages
The extensive macrophagic inflammation and microglial activation at3,7 and 28 days
following intra-parenchymal kaolin injection had been well demonstrated by
immunohistochemical methods (EDl) in the current study. Importantly, the extent of
inflammation was significantly underestimated on initial routine light microscopic
examination.
Gulian observed that following a stab injury to the rat brain, 2 apparently distinct
populations of Dil-ac-LDL(+) cells could be observed as early as 5 hours.r30' 
r3r They
concluded that the round cells were "extrinsic mononuclear phagocytes" which had
invaded the site of the stab wound. In contrast, the ramified cells with newly expressed ac-
LDL receptors were thought to reflect activated microglial cells distant to the imediate site
of injury. This interpretation appears to be relatively accurate on the basis of our findings.
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However, many EDl* cells were observed in the current study that could not be classified
into either morphological categories.
When cell counts were performed, approximately half of the EDI positive cells were
derived from the bone marrow (RT7.2*) at all sacrifice intervals (FIGURE 23). These
were typically large, round cells with foamy cytoplasm which fitted the classical
description of macrophages. Conversely, an equally large proportion of,ED I positive cells
(instead of EDI positive macrophages) are therefore of presumed microglial origin. This
cautious and qualified conclusion is made because it is recognised that both macrophages
and'activated'
135









3 Days RT7.2 positive cells
7 Days
trRT7.2 positive cells IEDI positive cells
tr'igure 23. Counts of RT7.2 and EDI immunoreactive cells in chimeric
rats sacrifrced at 3 dnys,7 dnys and28 days. The EDI inflammatory
reponse was most marked at 7 days. At all time intervals, approximntely
half of the EDI+ cells were derivedfrom the bone matow (RT7.2+). The
rest of the EDI* cells are of presumed microglial origin.
28
microglial cells upregulate EDI expression. These cells of microglial origin (RT7.2-,
EDl.) demonstrate a continuous spectrum of morphological features, ranging from
'classical'macrophages near the kaolirVcord interface to other smaller and more distant
cells which are more typical of microglia. In a large number of cells, the origin could not
be determined based on morphological features alone.
3.3 Differential Functional Roles of Macrophages
In the rat spinal cord, the microglia-derived EDI* cells (RT7.2) were largely distributed
aroundthe kaolin droplet at 3 days and I week. By 4 weeks, significant numbers of
activated microglia were seen throughout spinal cord tissue sections at multiple levels both
rostral and caudal to the kaolin lesion. Overall, these cells were largely confined to the
parenchyma of the spinal cord, with a predilection for the white matter. In contrast, the
bone marrow derived macrophages appeared to be directed towards the kaolin particles.
By 4 weeks, these cells were totally confined within the kaolin droplet or within the
dilated segments of central canal. It is unclear whether the latter observation represents
direct migration of kaolinJaden macrophages into the canal or secondary recruitment of
macrophages to kaolin particles already present within the central canal.
While there is some evidence to suggest that microglial-derived macrophages demonstrate
different phagocytic potential to their haematogenous counterparts, the apparently
different roles of macrophages postulated has not previously been reported. In the current
study, the haematogenous macrophages appear to have a primary role in phagocytosing
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material foreign to the neural tissue. Theoretically, this may also include other'foreign'
material such as blood, infective agents etc. On the other hand, macrophages of microglial
origin appear to be most active within the neural tissue, possibly playing a key role in
phagocytosing myelin. This is consistent with previous studies which have shown that
microglia possess a significantly greater myelinophagic capacitf'. Howerret,
ultrastructural studies were not performed and would be required to confirm this
hypothesis.
3.4 Microglial activation
3.4.1 Microglial response in ønimal models
The phenomenon of microglial activation has been well demonstrated in experimental
animal models. It occurs in response to brain trauma, T cell-mediated inflammation, global
and focal ischaemia, transplants into the brain, experimental gliomas and viral and bacterial
infections2T'
3.4.2Microglial response in spinal cord injuly
The pattern of microglial activation following spinal cord injury has been evaluated in a
number of recent studies.
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Koshinaga and Whittemore utilised the photosensitising dye rose bengal and an argon dye
laser to induce a spinal cord lesion at T8, thus severing axons of the dorsal columns and
corticospinal tracts.2o3 This led to rapid microglial activation. Interestingly, the pattern of
activation appeared to be both temporally and topographically specific. For example at
T4-5 two days postJesion, they observed striking accumulation of cells with intense CR3
receptor immunoreactivity in the fasiculus gracilis, but little change in the corticospinal
tracts and fasiculus cuneatus. The explanation for this observation is not known although
the authors suggest that this may be related to differences in æronal properties. Watanabe
et af2s reported similar findings after either totally transecting or severely compressing the
spinal cords of Wistar rats. They observed at least 2 different spatial and temporal patterns
of microglial activation. Interestingly, Watanabe et ø/ postulated that the early pattern
possibly involves the blood borne complement activating system while the later response
accompanies Wallerian degeneration and is independent of the complement system. Dusart
and Schwab further observed that a significant microgliaVmacrophagic reaction (using
EDI and OX42) may persist for at least 3 months after transecting the dorsal one half to
two-thirds of the rat spinal cord .88
3.4.3 Mechanisms of miuoglial activation
The curent study has provided evidence of early microglial activation with EDI*
expression within the spinal cord parenchyma in rat syringomyelia. In fact, the microglial
cells were the earliest cells to migrate into the kaolin droplet (at 3 days). They were
subsequently replaced by their haematogenous counterparts at later time intervals. These
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findings are consistent with Kreutzberg's theory that the microglia act as "sensors" in the
first line defence of the central nervous system.
The activation of remote microglial cells following relatively mild injuries suggest that fast
activation pathways are operating. Thomas monitored living microglial cells using time-
lapse video recording and found that individual cells were capable of assuming a different
morphology *itún 5 minutes.3ea
The potential routes and mechanisms of these processes are difficult to delineate.3ra
Recently, it has been proposed that the presence of an inward rectifying K* channel
without an outward channel may account for the microglial sensitivþ to the ionic
environment.il'a2a These microglial channels are probably linked to P2 purinoreceptors
which may become activated by ATP release.2T C¡okines such as macrophage colony
stimulating factor (M-CSF) and granulocyte macrophage colony stimulating factor (GM-
CSF) may influence the expression of K+ channels in macrophages."
Binding of antibodies to surface receptors such as complement receptor 333r may also lead
to rapid microglial activation. ATP which is released during cellular damage can lead to
the same process by binding to membrane receptors.a2a
The function of microglial'activation'is unknown. Whether such a response is purposeful
or a non-specific reaction to neural injury remains poorly understood. It is possible that
the activated microglia may assist in further recruitment of haematogenous macrophages
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to the site of neural injury. Certainly, our observations of earþ microglial migration into
the kaolin droplet which precedes the influx of haematogenous macrophages does not
contradict this hypothesis. However, it is possible that the "activation" process may be an
inevitable part of the transformation process into macrophages.
4 Macrophages in CNS
4.1. Response to CNS injury
Injury to the central nervous system results in tissue destruction at the site of injury.
Inevitably, this also leads to retrograde degeneration and Wallerian degeneration of axonal
fibres.3r0'3ra In particular, the process of retrograde degeneration is associated with a
prominent mononuclear phagocytic response that has largely been attributed to the
proliferation of activated microglial cells.2r6'380 In contrast, injury to the peripheral
nervous system leads to a delayed but extensive recruitment of monocytes.3lo'3lt
Within the central neryous system, haematogenous macrophages are generally considered
to be the main source of cells that phagocytose myelin.3oe Similarly, they also assist in the
subacute and delayed phases of myelin breakdown when peripheral nerves undergo
Wallerian degeneration.s'373 Phagocytosis by macrophages occurs after binding of the Fc
receptor to antibodies on the myelin surface"'''ut ot by binding to complement via
complement receptor 3.aB
r4l
4.2 Role of macrophages in the uninjured CNS
The role of macrophages in the central neryous system is controversial.
On one hand, macrophages are deemed to be beneficial to neuroanatomical repair. It has
also been suggested that these cells may modi$ the nonpermissive nature of the adult
CNS although the mechanisms have not been clearly defined.?o Macrophages may remove
myelin debris, which is known to inhibit axonal regrowthso'34e, recycle lipid degradation
productsl56,374'382 or secrete cytokines and growth factors.165 Recent research has further
shown that the direct implantation of activated microglia/macrophages into the site of
neural inj ury promotes axonal regeneratio n.tos' 
2t7' 320' 323' 328' 35 I
On the other hand, macrophages have also been thought to be key effectors of cellular
damage in neural injury and demyelination.2a'32'33'82' 
20e In animal models of both
inflammation (EAE) and spinal cord injury, macrophage depletion or deactivation leads to
either amelioration of symptoms or improved neurological outcome.22'34'47'r78'2sr'318'400It
has been postulated that the absence of macrophages may limit chondroitin sulfate
proteoglycan deposition and reduce release of injurious agents such as superoxide radicals,
hydrogen peroxide, hypochlorous acid, quinolinic acid as well as other proteolytic
enzymes."* Furthermore, the use of anti-inflammatory agents such as methyprednisolone
following induced spinal cord injury in rats reduced the extent of damage and prevented
injury induced hypothermia.oto More recently, these benefits have been reproduced in the
clinical context. The administration of methyl prednisolone within 8 hours of the human
spinal cord injury had been shown to improve neurological outcome.3'450
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Such apparently contradictory data may be partially reconciled by an understanding of the
following factors:
(1) In the post-injury phase, it is important to distinguish 2 complementary processes:
neuroprotection, the rescue of spared axons and neural regeneration which involves the
regrowth of transected nerves.3tt These processes vary depending on the type and extent
of CNS inj.try studied.
(2) The microenvironment in which microglial and macrophagic activation occurs is
known to influence their neurotrophic or neurotrophic expression .28e'453 Lazarov-Spiegler
and colleagues demonstrated that transplanted macrophages preincubated with peripheral
(sciatic) nerye were endowed with greater phagocytic activity and induced superior axonal
regrowth within the central nervous system in comparison with macrophages which were
pre-incubated with optic nerve segments.2lT'218 The researchers conclude that an'immune
privilege factor' inhibits macrophagic migration into the central nervous system.2le This is
believed to lead to a broad range of effects which either make the CNS environment
growth-supportive or growth-inhibitory.217
(3) The role of other non-neuronal cells within the central neryous system may also be
important. For example, the astrocytes are known to have many important functions in
development, homeostasis and response to CNS injury.3o8
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Clearly, a better understanding of the signals controlling macrophage activation is
required.
5 Contribution to pathogenesis of syringomyelia
5.1 Pathological basis of syringomyelia
Syringomyelia is a heterogeneous pathological entity associated with varied aetiologies. It
is therefore highly unlikely that an all-embracing pathogenetic theory can account for the
formation of all forms of syingomyelia.
In the communicating form of syringomyelia, co-existing hydrocephalus appears to be the
key feature. This is reflected in both MRI scanning2u6 and also post mortem autopsy
studies26e. The hydrodynamic theories of both Gardner and Williams are likely to be
relevant. As the ventricles enlarge in the setting of impaired CSF outflow from the fourth
ventricle, the central canal enlarges as a compensatory mechanism. Occasionally the CSF
may dissect into the spinal cord parenchyma.
However, MR imaging has demonstrated that less than l}Yo of cavities communicate
directly with the fourth ventricle although the compressed or distorted segment of the
central canal may be anatomically patent at the time of autopsy.'ut The largest autopsy
series further confirmed that the majority of syrinxes are either of the non-communicating
or extra-canalicular varieties.26e In these cases, ventricular CSF pressure cannot be
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transmitted directly from the fourth ventricle into the syrinx. Other factors must therefore
come into play
We hypothesize that macrophages/activated microglia may play an important role in the
pathogenesis of at least some forms of syringomyelia- in particular the non-communicating
and possibly the extra-canalicular varieties. This is largely based on pathological evidence
showing that macrophages are a particularly prominent finding in the spinal cord
parenchyma of both these forms of human syringomyelia. The role of these cells in
syringomyelia has not been evaluated systemically to date.
5.2 Rat model of non'communicating syringomyelia
In the past, cisternal injection of kaolin was one of the most widely used approaches to
induce hydrocephalus and concomitant syringomyelia. However, this is less clinically
relevant as syringomyelia is rarely associated with overt hydrocephalus in clinical practice.
Milhorat et al first described a reproducible experimental rat model of non-communicating
syringomyelia which involves an intraparenchymal injection of kaolin into the cervical
spinal cord. This model has also been particularly valuable for the study of CSF dynamics
in relation to the syrinx."t'"t
The pathology of kaolin-induced noncommunicating syringomyelia is thought to occur in
step-wise fashion as follows2ut, (1) initiation of a localised inflammatory reaction at the
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kaolin injection site (2) drainage of inflammatory products rostrally within the central
canal (3) occlusion of the central canal by proliferating ependymal cells and astrocytes and
(4) dilation of the obstructed segments of the canal.
Inflammatory mediators produced by activated microglia and accumulating macrophages
may be driven by CSF flow into the central canal . This may induce ependymitis and
ependymal proliferation rostral to the site of injection. The obstruction to "normal"
upward CSF flow within the central canal eventually results in distension of the central
canal. While convincing evidence of CSF flow trans-parenchymally from the subarachnoid
space into the central canal has recently been presented, a rostral pattern of normal flow in
the central canal still remains to be proven.2l
In an earlier work. Milhorat and his colleagues performed similar intraparenchymal
injections of blood into the dorsal columns of rat thoracic spinal cords 1T5-6).265 This
resulted in a significant microglial reaction locally at the site of injection. While
erythrocytes, cellular debris and fibrin were observed within the central canal, neither
central canal occlusion or syrinx formation was observed. This suggests that certain
specific characteristics of the kaolin induced inflammation are important for syrinx
formation. Unfortunately, these are not known.
5.3 Sink action hypothesis
In the current study, the macrophages and activated microglia appear to converge
centripetally onto the central canal. This was particularþ so at 4 weeks. It is not known
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whether this represents the direct migration of EDI* cells from the kaolin droplet toward
the central canal or'static'by-stander cells that have been activated by inflammatory
mediators carried by the inward CSF flow. Despite this, these observations appear to
provide support for the'sink action hypothesis' of the central canal. It is consistent with
current understanding of transparenchymal CSF flow from the subarachnoid space.
Subsequent CSF flow into the central canal may occur through enlarged Virchow-Robin
spaces or the dorsal roots.l0' 'u' Other possible sources of a net increase in syrinx fluid
include inflammatory products, ependymal secretions and interstitial fluid derived from
water during metabolism.26T
Some animals in the 4 week study group demonstrated marked macrophagic aggregation
within enlarged central canals. We speculate that this may potentially lead to further
enlargement of the cystic cavity in some animals (FIGURE 24).It is likely that as the
macrophages die or disappear, alarge cystic cavity results. Continued CSF egress may
lead to further extension of the cavity. Such a pattern of macrophage-filled syrinx may not
be readily observed in human pathology because these studies are not typically performed
in the acute/subacute stages of the disease. This hypothesis remains speculative at present
and further research is necessary to clarify this.
5.4 Other forms of syringomyelia
Macrophages may also play a significant role in the initiation of extra-canalicular
syringomyelia associated with conditions such as trauma and ischaemia. Multiple
microcystic cavities may initially form as a consequence of macrophagic phagocytic
t47
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activity. These may subsequently coalesce to form a typical syrinx. Continued CSF flow






Figure 24. Proposed pafhogenetic mechanísms in non-communìcatíng røt
syrìngomyelia. A local macrophagic inflammatory infiltrate occurs early within
the spinal cord parenchyma at the site of kaolin injection. Inflammntory
mediators secreted by macrophages and activated microglia are carried by
inward transparenchymal CSF flow into the central canal.This leads to
ependyrnitis and canal occulsion rostral to the site of injection, resulting in an
"obstruction" to upwardflow of CSF. The central canal subsequently ttilates. In
some cases. mncrophages further accumalate within the central canal causing
further dilation. It is postulated that as these macrophages eventually dßappiar,
a large syrinx results. Continued CSF egress mny maintain or cause further









6 Limitations of the current research
Several potential limitations of the current study must be considered:
(l) The kaolin-induced model of non-communicating syringomyelia reproduces many of
the pathological features (including macrophages) seen in human syringomyelia.
However, it involves anintra-parenchymal injection of a foreign substance (kaolin) into
the spinal cord substance. While this is not ideal, the current animal model represents the
only reproducible model of noncommunicating syringomyelia to date.
(2) The irradiation of spinal cord tissues in the RT7.1 DA rats may theoretically alter the
behaviour and activation of endogenous microglial cells. However, there is no evidence of
EDI upregulation in the spinal cords of control chimeric rats. Furthernore, the pattern
and magnitude of EDI immunoreactivity of chimeric rats were not significantly different
from the non-irradiated rats at 3 days and 4 weeks.
(3) There is a theoretical possibility that some haematogenous cells may alter or down
regulate their expression of the R.T7 .2 antigen as they enter the central nervous system.
There is no literature to suggest such a "down regulation" phenomenon has ever been
observed and is therefore considered to be extremely unlikely.
(a) The counting of immunoreactive cells (as performed in the current study) has well





section depends on the orientation of the section (transverse or longitudinal) and the
precise level of the spinal cord where the section was obtained. In the current study, cell
counting was performed on transverse tissue sections at the level where the cross sectional
area of the kaolin droplet was the largest. It is the author's opinion that the cell counts
when coupled with descriptive observations, provides a balanced view of the relative
contributions from macrophages of different origins in the current rat model of non-
communicating syringomyelia.
(5) Another criticism of the current proposed pathogenetic theory is that it requires a
patent central canal. The critics argue that progressive stenosis ofthe central canal occurs
in humans with increasing age. It has been widely accepted that in TlYo to 80oZ of normal
subjects the central canal of the spinal cord closes and becomes a vestigial structure
represented by a core or nests of ependymal cells.65 However, the implications of these
findings are not entirely clear. For example, it is not known whether humans whose spinal
cord central canals remain patent throughout life are more prone to syringomyelia.
Furthermore, apparently stenosed or occluded central canals may still be functionally
patent despite their histological appearances.
7 Conclusion
A large proportion of the macrophages has been derived from the bone marrow in the
current rat model of non-communicating syringomyelia. At all time intervals, this
represents nearly 5O%o of allEDl* cells. In addition, there has also been significant









has also provided evidence that the haematogenous macrophages appear to have different
functional roles from their microglial derived counterparts.
8 Future research
The use of rat radiation bone marrow chimeras has provided an answer to the origin of
macrophages in a well established noncommunicating model of rat syringomyelia. This is
both a fundamental neurobiological as well as pathophysiological question that has not
previously been addressed.
We have postulated that macrophages play a central pathogenetic role in the initiation of
noncommunicating syringomyelia although this hypothesis has not been tested directly in
the current work. A logical extension of the current work would therefore be to study the
effect of macrophage depletion on rat syringomyelia.
Our results suggest that to achieve this, the therapeutic agent possibly needs to deplete
both microglial as well as bone marrow derived macrophages effectively. Furthermore, the
agent must be sufficiently specific in its actions, so that any observed result cannot be
attributed to other immunosuppressive functions. Such an agent has recently become
available.rTs' 
318 W1úle it probably does not cross the blood brain barrier, it appears to







Previous departmental work has shown that post-operative administration of
dexamethasone and indomethacin reduces early syrinx formation at one week but not at 6
weeks. While these results appear to contradict the proposed inflammatory hypothesis,
two factors must be considered. Firstly, the doses of the inflammatory agents used may
not be optimal. Secondly, these agents may not be the ideal agents in targeting
mononuclear phagocytes. While glucocorticoids appear to inhibit proliferative and
secretory functions of monocytes/macrophages in vitroae, Giulian et al observed that
dexamethasone (0.8 mg/kÐ in vivo neither inhibited the phagocytic activity in
mononuclear phagocytes nor influenced astrogliosis or neovascularisation at the sites of
brain injuryr3o. Furthermore, both the activation and proliferation of microglia also did not
appear to be affected by glucocorticoids.53
The other possibilities that stem from this work include;
(l) the application of rat radiation bone marrow chimeras to determine the origin of
macrophages in other experimental models such as stab injuries and fat embolism to the
brain.
(2) specifically studying the response of microglial cells in conditions such as experimental
head injury, hypoxic brain injury and brain tumours.
(3) studying the spinal cords of rats with longer periods of survival (e.g. 6 to12 months)
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From: Graham Mayrhofer <gmayrhof@gina.science.adelaide.edu.au>
To: Gabriel Lee <glee@digitech.net.au>
Date: Friday, September 11,1998 1:50 PM
Subject: Re: microglia/macrophages
At 05:44 PM 9/10/98 +0930, you wrote:
>Dear Dr Mayrhof,
>l spoke to you the other day on the phone regarding how one might be able
to distinguish the macrophages from microglia by immunological means. Since
then I have spoken with Professor Holt and quite a few other researchers.
>l became interested with the concept of using chimeric animals/rats which
differ by only one allelle such that a group of cells can be identified
with particular and specific antibodies. ljust wonder if you have
experience with such an experimental technique please?




The answer is yes and we have one such congenic pair of rats.
Perhaps we should meet and discuss your requirements, because we have just








Phone: 61 I 303 5389
FA)t 61 I303 4362
Email: gmayrhof@microb.adelaide.edu.au
\A/\MA/: http://www. microbiology. adelaide. edu. au/index. htm
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From: William F. Hickey <William.F.Hickey@Hitchcock.ORG>
To: glee@digitech.net.aucglee@digitech.net.au>
Date: Saturday, January 16, 1999 2:41 AM
Subject: Rat radiation chimeras
DEAR DR LEE,
THANK YOU FOR YOUR NOTE. I WILL PROVIDE ANSWERS TO THE EXTENT I CAN.
(1) what were the approximate weights of the rats you used? WE USE RATS OF
APPROXIMATELY 1 50. GRAMS.
(2) what antibiotic regimen did you use (type/route/duration) etc? WE HAVE NEVER USED
ANTIBIOTICS, NOR HAVE WE HAD TO. THE RATS DO VERY WELL ON THEIR OWN.
(3) what was the mortality rate following the irradiation process (with the cell transfers) at 2
months and when did these rats (if any) died?
OUR MORTALITY IS ZERO. THE RATS TOLERATE THIS WHOLE PROCEDURE VERY
WELL. HOWEVER, THERE IS AN IMPORTANT POINT TO MAKE: USE THE MARROW
FROM ONE ENTTRE RAT (BOTH FEMURS, BOTH TTBTAE AND BOTH HUMERI) TO
MAKE THREE CHIMERAS. DON'T TRY TO ''STRETCH'' THE BONE MARROW INTO
FIVE OR SIX RATS. IT JUST ISN'T ENOUGH. YOU NEED ONE DONOR FOR EACH
THREE RECIPIENTS. ALSO, IT IS VERY IMPORTANT TO BE GOOD AT TAIL VEIN
INJECTIONS. ALL THE MARROW MUST GO INTO THE TAIL VEIN.
WE USE IRRADIATION OF 1OOO. RADS GIVEN IN A SINGLE DOSE OVER ABOUT 5
MINUTES.
THERE IS ANOTHER VARIATION WHICH COULD ALSO HELP. IF IT IS NOT CRITICAL
THAT YOU GIVE ONLY BONE MARROW CELLS, YOU CAN REMOVE A SPLEEN AND
LYMPH NODES FROMT HE DONOR ALSO. IF YOU INFUSE THESE WHEN YOU
INJECT THE BONE MARROW, YOU ARE GIVING THE RECIPIENT A ''PREFORMED''
IMMUNE SYSTEM. IT WILL NOT HAVE ANY PROBLEMS. OF COURSE, NOT KNOWING
YOUR RESEARCH GOALS, I CANNOT SAY WHETHER THIS WOULD BE
APPROPRIATE.
ALL OF THIS ASSUMES THAT YOUR ANIMAL COLONY IS REIATIVELY CLEAN. IF
YOU HAVE DIRTY ANIMALS, THEN THE INFECTION RATE WILL NOT BE LOW.
IF YOUR RATS DIE BECAUSE OF THE IRRADIATION, THEY TYPICALLY DO SO
BETWEEN 8 TO 10 DAYS FOLLOWING THE IRRADIATION ........... BUT, AS I'VE SAID,
WE'VE NEVER HAD IT HAPPEN.
(4) d¡d your rats lose considerable amounts of weight following the radiation?
/'¿t0t
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NO, THE RATS DO VERY VERY WELL. NO DIARRHEA OR BLEED¡NG, AND
TYRPICALLY NO INFECTIONS. HOWEVER, WE GIVE THE RATS THE BONE MARROW
TRANSFER ABOUT 4 HOURS AFTER THEY HAVE BEEN IRRADIATED. WE DON'T
WAIT DAYS.
I WISH YOU THE BEST OF LUCK. I HOPE THIS ADVICE HELPS. CHIMERAS ARE A
VERY POWERFUL RESEARCH TOOL, AND THE RAT IS A VERY GOOD ANIMAL





From: William F. Hickey <William.F.Hickey@Hitchcock.ORG>
To: glee@digitech.net.aucglee@digitech.net.au>
Date: Thursday, January 21, 1999 9:06 AM
Subject: Re: Rat radiation chimeras
DEAR GABRIEL,
MY RESPONSES ARE IN UPPER CASE. I AM SORRY FOR THE DEI.4Y....... BUT
THERE ARE
oTHER TSSUES TO WH|CH r MUST ATTEND (ALTHOUGH I PREFER RESEARCH).
I irradiate my rats at the same dose of 1000 rads at 95 rads/min. (NO PROBLEM
WITH THIS). They started losing weight the same day (BAD SIGN...SOUNDS LIKE
INFECTION OR RADIATION POISONING) for a total of 4 days before plateauing. As
you said most have died at day 6-7 . We used prophylactic gentamicin as
suggested by the vet. HERE I HAVE FOUR THOUGHTS. FIRST, lF YOUR ANIMAL
COLONY HARBORS PATHOGENS, AND EVERY RAT ENTERING BECOMES INFECTED
(MYCOPT.ASMA
ts oNE oF THE ONES I HAVE tN M|ND), THEN |RRAD|AT|ON WILL ELIMINATE THE
IMMUNE
RESPONSE AND THE RATS DIE. SOME FUNGIAND PROTOZOAN INFECTIONS
COULD DO THE
SAME. SECOND, IT COULD BE AS SIMPLE AS TRANSFERING TOO FEW STEM
CELLS AND NO
TMMUNE CELLS (REMEMBER..... DOES YOUR RESEARCH OBJECTIVE REQUIRE THE
USE OF
ONLY STEM CELLS?? IF IT DOESN'T, THROW IN A SPLEEN FOR THE RATS'
HEALTH! THRE
ARE SOME SCIENTIC QUESTIONS WHICH WOULD PREVENT THIS, BUT NOT
MANY.) THTRD,
THE CALIBRATION OF YOUR SPECIFIC IRRADIATOR MAY BE OFF .... IT MAY BE
WAY, WAY
OFF. ASK THE GROUP THAT OVERSEES THE IRRADIATOR FOR CALIBRATION
DATA. YOU
MAY BE LITERALLY FRYING YOUR RATS. FOURTH AND FINALLY IS SOMETHING I
SUSPECT
MAY BE AT THE ROOT OF THE ISSUE. YOU ARE USING GENTEMICIN. THIS IS
NEPHROTOXIC. ARE YOU KILLING YOUR RATS WITH UREMIA BECAUSE YOU ARE
SEVERELY
DAMAGING THE KIDNEYS WITH WHAT MIGHT BE MASSIVE DOSES OF GENT??
YOU SHOULDN'T
NEED ANTIBIOTICS AT ALL IN A CLEAN COLONY AND WITH PROPER IRRADIATION
AND
APPROPRIATE STEM CELL TRANSFER. IF YOU DO NEED THEM, THEN
TETRACYCLINE IN THE
DRTNK|NG WATER tS THE WAY I'D GO (CHAT WITH YOUR VET).
tl'2lUI
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We used 1 x 10-7 cells for each rat. This meant that we used up to1 donor
rat for 12 DA rats. I was therefore again surprised that you used a donor
for 3 rats. We also injected the rats within 4 hours. We also know that the
cells are immuno-histocompatible from skin grafts and previous cell
transfers. After the injections, our rats were kept in cages of 3. YOUR
TRANSFERED CELL NUMBER lS VERY MUCH TOO SMALL. (ALSO SEE ABOVE).
Couldyou tell me please if you have irradiated DA rats before? I USE THEM
ROUTINELY. NO DIFFERENCE FROM OTHER STRAINS WITH REGARD TO
SENSITIVITY TO
RADIATION, ETC. PLEASE FILE THIS NOTE AWAY FOR FUTURE REFERENCE
RELATIVE TO
RATS IF YOU USE DA RATS. I HAVE A RAT CALLED THE DA(RP) RAT. ITS GENES
ARE
DA EXCEPT FOR THE MHC CLASS TWO MOLECULES. THOSE ARE RT-11 (LIKE
LEW|S).
THERE MHC CI.ASS ONE GENES ARE NOT LEWIS. SHOULD THIS TYPE OF RAT
EVERY BECOME
INTEREST|NG TO yOU RELATTVE TO YOUR STUDTES (ESPECTALLY FOR MAKING
VERY
TNTERESTTNG CHIMERAS) LET ME KNOW.
Were they housed in separate cages after the injection of cells? NO - GROUPS
OF 3 WORKS BEST....THEY GET LONELY AND STRESSED IF HOUSED ALONEWeTe
they reared
in special conditions prior? NO WAY!
I SINCERELY HOPE THIS INFORMATION GETS YOU OFF THE GROUND. THERE'S
NO
QUESTION YOU'RE BATTLING TECHNICAL PROBLEMS. LUCKILY, THEY'RE CAN BE
CORRECTED....UNLESS YOU HAVE AN ENDEMICALLY INFECTED ANIMAL FACILITY.
IF
THAT'S THE CASE, FIND ANOTHER ONE ON CAMPUS OR NEARBY THAT IS CLEAN,
AND MAKE
ARRANGEMENTS TO HOUSE THE CHIMERAS THERE WITHOUT EVER PASSING
THROUGH THE DIRTY
COLONY.





To: Gabriel Lee <glee@digitech.net.au>
Date: Friday, February 12, 1999 6:10 PM
Subject: RE: Re: Re: Re: RT7.2
Dear Dr Lee,
Hello again!
The clone originator for MCA473S is going to contact me on Monday. Apparently, he has
not been in the lab this week which explains the delay in replying to me.
Serotec QCs most antibodies in flow cytometry. The information concerning the use of our
antibodies in immunohistology is generally obtained from published references, from clone
originators or sometimes from external testing where we send samples of our antibodies
away for testing. At present, our labs are not set up for immunohistology, although in the
near future we will be beginning an immunohistology project testing our antibodies "in
house".
Although you have had little sueÆess with the tissue culture supernatant supplied by another
company, I would be surprised if a dilution of 1/50 would work as we recommend using
supernatants neat-1/S. Typically, supernatants have an antibody concentration of between
10 and 50 micrograms per ml (unless of e¡urse they are concentrated supernatants).
As soon as the clone originator for MCA473S contacts me on Monday, I will e-mail you the
information lreceive.




Sent: 11 February 1999 05:49
To: Emma
Subject Re: Re: Re: RT7.2
Dear Emma
I was wondering if there was any chance that the Serotec laboratory could
actually test the product of RT7,2 antibody on paraffin sections on a
semi-urgent basis (ie in the next few days)? I suspect that this may be much
faster than waiting for a reply from the clone originator to confirm the
information on the data sheet.
t2ttJt
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will certainly test it as soon as I obtain the samples although this will
:ertainly take up to the end of next week at the very earliest. However,
¡hould your lab be able to reproduce the results on paraffin sections, this
rvould give me some confidence that the procedure really works.
Unfortunately, I am due to start on my animal work early next week and thus
I would need to have a definite plan as to whether I proceed with paraffin
sections or frozen sections by the end of next week.
in fact yesterday I got a sma]laliquot of the RT7.2 antibody from a
neighbouring laboratory (BUT from a different product company) to test its
=fficacy 
on paraffin sections. Due to the small volume that was given, I
made a 1l2O dilution (enough for 2 slides). Unfortunately even with a nickel
DAB technique it does not appear to have worked at all. I did not see any
staining at allwheras I expected to see perhaps patchy staining even at
this low dilution. lt is also a supernatant product and this has perhaps
made me even more keen to demonstrate that the Serotec product does
certainly work on these sections as stated on the data sheet. Despite a
number of possible reasons for failure to work (including the dilution
factor), the situation is rather worrying.
I look forward to a reply from the clone originator and hope that the






To: Gabriel Lee <glee@digitech.net.au>
Date: Tuesday, February 09, 1999 10:41 PM
Subject RE: Re: Re: RT7.2
>Dear Dr. Lee,
>Serotec couriers all products to Australia by air (when I say shipping, I
really mean despatching). The products will therefore take 2-3 days to get
to our Australian distributor. I cannot say how long it will take for the
products to reach you once they are in the hands of the distributor as I do
not know which system is used to pass on the produc'ts. Perhaps you could
contact the distributor to ask how long it will take once the products are
in Australia.
>l hope this will resolve the situation and please don't worry about
















oSent: 09 February 1999 23:07
rTo: Emma
'Subject Re: Re: RT7.2
>Dear Emma
>Thank you for taking the trouble to contact the clone originator. I will be
>most interested in what you find out.
>Thank you also for sending the free vials of antibody. However, I am afraid
'shipping witl imply another delay of at least 2-3 weeks. My testing of the>antibody has already been delayed by at least 3 weeks and a further delay
>would not be helpful at all. ln fact, I had spoken with the representative
>at Jomar Diagnostics toady to arrange an urgent courier service ie by air
jf
>this was possible. This antibody is critical to my current research and I
>hope that Serotec would be able to kindly assist in this matter.
>My numerous e-mails must be wearing you down. I am efremely grateful for
>all the help that you have given over the phone as well as via electronic
Þmail.
>l look forward to your reply with regards to both the information of
>staining paraffin sections as well as delivery of the antibody samples.





>To: Gabriel Lee <glee@digitech.net.au>
>Date: Tuesday, February 09, 1999 7:20 PM
>Subject: RE: Re: RT7.2
>>Dear Dr. Lee,
>>Thank you for your e-mail regarding the free of charge vials of MCA473S
>>l have arranged for these to be shipped to our Australian distributor











'>l will be contacting the clone originator of MCA473S today to discuss the
, 'suitability of MCA473S on paraffin sections. Unfortunately, I am unable to
'supply the details for the clone originator as this is confidential
'information, however, I will contact him today to see if there are any
lspecial conditions required for the technique.
'',2>
>>Once again, I would like to apologise for the problems you have











.>>Thank you for your fax which I received yesterday.
' >>lndeed the events that have occurred have been rather unfortunate.
However,
>>l am grateful for Serotec's offer of 2 free vials of MCA 473S (RT7.2 rat
>>antibodies). I will inform Jomar Diagnostics today to state that my
>>department will take up your kind offer. The testing of the antibody will
i'be
,:>>carried out as soon as possible and I am hopeful that the vials will be
>>delivered urgently.
>>l look forward to hearing from you with regards to the use of this
>>particular antibody on paraffin sec{ions or at least who the clone
>>originator. lf this information cannot be provided due to confidentiality,





t tt----original Message----i >>From. Emma <emma@serotec.demon,co.uk>












:>>l apologise for the confusion surrounding your order of MCA473.
>>>
'>>lt would seem as though you have received the ascites preparation
0.25m1)
'>which should be diluted approximately 1/500 for use on paraff¡n sect¡ons.
r>>
'>>l have searched through my files for information regarding the use of
'>MCA473 on paraffin sections and it appears as though the information was
'>obtained from testing by the clone originator of the antibody. As far as
>>am aware, the information has not been published.
>>>
'>>l am sorry | am unable to provide additional information at present. lf
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From: Emma <emma@serotec.demon.co.uk>
Ío: Gabriel Lee <glee@digitech.net.au>
pate: Tuesday, February 16, 1999 10:53 PM
Subject: RE: Re: Re: Re: RT7.2
)ear Dr Lee,
)nce again, I apologise for the delay in contacting you concerning the use of HlS41 on
¡araffin sections.
L can finally confirm that the recommended procedure for paraffin sections is as follows;
)e-paraffinise 4Yo paraformaldehyde fixed paraffin sections in xylene solvent and hydrate
hrough a graded series of graded alcohols. Wash twice in TBS.
llock endogenous peroxidase using 0.3% (w/v) hydrogen peroxide in methanol for approx.
l0 minutes. Wash in TBS.
3lock non-specific binding by incubating your sections in 1Ùo/o normal serum for approx. 10
nins. The serum should be from the species in which the secondary antibody is raised. I do
rot know which secondary antibody you are using so cannot advise as to the species of the
Serum to use.
lncubate the sections with HlS41 for at least t hour at room temperature. Wash 3 times in
,[BS.
\dd your enzyme-labeled secondary antibody at the recommended dilution (according to the
nanufacturers instructions) and wash in water.
Develop colour as normal.
I have been informed that microwave antigen retrieval may enhance staining. Should you
rwish to try this, the retrieval step should be performed following the endogenous peroxidase
block.










Date: Friday, February 19, 1999 6:12 PM
.Subjecfi Re: HlS41
)ear Dr Lee,
:have been asked to review the details of the problems that you have experienced, in
rarious ways, with our anti-rat RT7.2 antibody, product code MCA473.
:irstly I should add my apologies to those you have already received regarding the
¡onfusion about the format change from ascites to culture supernatant. The position with
egard to activity of the antibody in paraffin-embedded material appears to be rather more
nmplicated, and I should take the opportunity to review the position with you.
)ur information regarding the applications of the antibody originates from our supplier. ln
his particular instance our originating supplier is not in fact the clone originator - although
>ur confidentiality obligations do not permit us to identify our supplier, I believe that you have
low actually been in touch with the clone originator yourself. ln this respect you probably
ìave an advantage over us, as we are not able to contact them directly.
can confirm that our supplier originally indicated, and then confirmed, that the clone was
lctive in paraffin embedded material with the assistance of microwave antigen retrieval. lt
vould appear from a very recent communication (received after Emma forwarded you
nethodological details) that they cannot actually support this, which may reflect further
nformation that they have received from the clone originator. Obviously I cannot speculate
ls to the source of their original information, but can only be frustrated by the confusion it
ras caused.
/our latest e-mail raised a number of technical points, to which I will respond as far as
rossible below:-
1. With the exception of titre, antibody format (i.e. ascites vs. TCS) should not have any
rffect upon activity of an antibody in staining paraffin sections.
2. Staining intensity in paraffin sections may often be less intense than with the same
rntibody used in lrozen sec{ions.
l. lt could well be that the patchy weak staining you have seen reflects some fixation
lamage, which is likely to be additional to damage caused by the delay in processing the
)rgans after euthanasia.
3iven the support that we have received to date from our source I think it is fair to say that
Ne aîe unlikely to receive specific answers regarding fixation technique. We do not have any
Jata regarding expected expression of RT7.2 in heterozygotes, and I would not like to
ipeculate about this without any knowledge of the genetic background of the animals you
tre using, or indeed without any knowledge about the genetic dominance of RT7 alleles.
'¿lul
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)bviously I am unhappy with this situation, particularly regarding the unsupported claims
hat have been made by our supplier, and passed on in good faith by ourselves. My personal
eeling from your results is that the antibody is probably weakly active in paraffin-embedded
lissues, and that improved results may be obtained with even more sensitive detection
tystems (e.9. Streptavidin.ABG), although I am not in a position to be able to support this in
any definite way.
can offer a full credit in this case for your original purchase, but am aware from your
:orrespondence that you may prefer to use this clone in frozen sections instead. lf this is the
:ase I would be pleased to supply you with 2 further vials free-of-charge. I would be grateful
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To: Gabriel Lee <glee@digitech.net.au>
Date: Monday, February 22, 1999 9:'16 PM
iSubject Re: RT7.2 rat antibody
Dear Gabriel Lee,
Thank you for your resending the e-mail. I am very sorry for you to
hear the problems and frustrations related to the HlS41 antibody.




Protocol for ii munohistology:
1. Kill rat (does not matter how. We use now CO2 inhalation, but we
also have used overdosis ether or i.p. injections of euthasate).
2. Remove spleen and keep on ice in some PBS
13. Snap freeze spleen on piece of filter paper in liquid freon,
rliquid nitrogen or on dry ice. (You may use tissue-tec).
4. Store tissue at -70 until use.
5. Make tissue sections (5-7 um)
6. Let them dry thorougly (e.9. t hour room temp, with cold
haiblower).
7. Fix with acetone (best quality you can get; must be waterfree!),
10 minutes room temp.
8. Airdry, at least one hour (usually we do it overnight)
9. Wash slides one with PBS (room temp, 5 min)
10. lncubate with appropriately diluted antibody (if we do not know
the dilution, we take undiluted supernatants or 112O0 diluted
ascites, or 10 ugr/ml). lncubate for one hour at room temp. Do not
let dry out; use a humidified chamber!
11. Wash three times with PBS, 3 x 10 min, room temp
12. Incubate with second step reagent (we use rabbit anti mouse
,r¿tut
rage ¿ or J
nnjugated to peroxidase from DAKO). This reagent is diluted (1/50)
n PBS contaning 1% normal rat serum, to prevent unspecific staining.
ncubate for 30 minutes at room temp (humidified chamber)
tl3. Wash three times with PBS, 3 x 10 min, room temp.
:l4. Develop peroxidase, e.g. with diaminobenzidine as usual.
15 counterstain if needed with hematoxylin, dehydrate and mount
sections in Depex.
I hope this willwork.
Question #2:
You can store the tissues at -70 in small containers for many years
Question #3:
Heterozygotes have enough RT7 to show up
Question #4
Staining pattern should be clear and easy for interpretation. The
only problem you may encÆunter when you are dealing with macrophages




Yes, no problems with culture supernantants.
I hope this will help to fix the problems. Please do not hesitate to
contact me again, and I would like to hear whether it works or not.
Best regards,
Frans G.M. Kroese
Dr Frans G.M. Kroese
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From: William F. Hickey <William.F.Hickey@Hitchcock.ORG>
To: glee@digitech.net.aucglee@digitech.net.au>
Date: Wednesday, March 31, 1999 11:47 PM
Subject: Re: lnterpretation of EDl macrophage marker staining pattern
Dear Gabriel.
The counting is difficult. I believe that ED1 stains BOTH activated microglial cells and
infiltrating macrophages fromthe blood. The question of cross staining of neutrophils with
ED1 is of little concern since in rat EAE there are virtually none of these in the CNS. The
smaller cells you mention are probably microglial cells that are becoming activated (but
remember some small percentage of your large "macrophages" started as microglia.




From: CD Dijkstra <CD.Dijkstra.Cell@med.vu.nl>
To: glee@digitech.net.aucglee@digitech.net.au>
Date: Tuesday, April 06, 1999 6:56 PM
Subject: re: EDl
Dear Dr. Lee,
As for the ED1:
The original observation was that ED1 does not stain granulocytes and indeed
in tissues granulocytes are normally negative for ED1. However, in a personal
communication by Jurgen Westermann I lerned that granulocytes in the
peripheral blood are sometimes positive for ED1. I have never seen ED1
positive granulocytes in the CNS.
As for your second question: indeed (activated) microglia can be positive for
ED1, we often observe that in EAE. I agree with you that this makes
quantification of macrophages in the GNS difficult in your model. Morphology
is in fact maybe the most reliable feature to discriminate between macrophages
and microglia. Maybe you should also look in the papers of Jon Sedgwick for






I am a neuro-surgical researcher working on a post-graduate degree. I am using
rat radiation chimeras to study the origin of CNS macrophages in my rat animal
model.
I wonder if I could seek your kind advice on several aspects of the monoclonal
antibody of ED1 which you originated. lt would be very much appreciated.
(1) Does ED1 label neutrophils as well- the data sheet from Serotec suggests
that it does stain neutrophils wheras your publication seem to suggest that it
does not. ln other words, can I be confident that in an ED1 positive




(2) I stain ED1 macrophages in the CNS (rat model). The staining intensity is
usually very strong. However, there are smaller areas which stain more weakly-
do you accept these as being macrophages as well? These variations in terms of
staining intensity leads to difficulty in confident macrophage counting. I
believe that activated microglia are also ED1 positive- would this be your
experience as well?
I apologise for taking your time but know that there is probably no better
person to seek advice on this matter than yourself.
Thank you kindly again.
Kind regards
Gabriel Lee (Dr)
End of Original Message
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From: HansLassmann<hans.lassmann@univie.ac.at>
To: Gabriel Lee <glee@digitech.net.au>
Date: Tuesday, April 13, 1999 9:55 PM
Subject: Re: lnterpretation of ED1 macrophage marker staining pattern
Dear Mr. Lee:
Thank you very much for your message dated March 31, 1999. lndeed ED1
stains both, macrophages as well as microglia. We have addressed this point
in detail in a paper (Rinner et al, Glia 14:257-266; 1995) which by using
bone marrow chimeras clearly shows that both, macrophages and microglia
express this marker. ln our hand ED1 does not stain neutrophils, at least
in paraffin sections. For detailed cell identification we use rather thin
paraffin sections for EDl staining and counterstain them with hematoxylín.
ln this case it is easy to define the different cell types by cell and
nuclear morphology. I hope this information is usefulfor you.
With best regards,
yours sincerely,
Prof. Dr. Hans Lassmann
At 23:30 31.03.1999 +0930, you wrote:
>Dear Professors Hickey and Lassmann
>Thank you for your previous advice on creating rat radiation chimeras.
That aspect has gone rather smoothly and been quite successful. I am
currently at the stage of looking at and analysing the results to assess
the percentage of exogenous macrophages.
>l wonder if I could further trouble you by asking for your kind advíce
with regards to the use of the ED1 macrophage marker. My staining pattern
within the central nervous tissue shows that the macrophages stain
extremely strongly with Nickel DAB (in my model). ln fact in a dense
infiltrate, it proves quite difficult to count the number of macrophages.
Furthermore, there are also much smaller smaller cells which stain
positively (looking quite distinct). I presume that these are activated
microglia- is that your experience? The data sheet from Serotec also
suggests that neutrophils may stain weakly with ED1- how do you overcome
this problem of trying to decide which cells are in fact macrophages when
you perform a count.
>l am most grateful for your advice and experience. This has presented a
real problem for me.
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>Thank you once again and I apologise for the inconvenience.
>Kind regards
>Gabriel Lee
>Attachment Converted: "G:\MA| L\lnterpre"
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From: Graham Mayrhofer <graham.mayrhofer@adelaide.edu.au>
Io: Gabriel Lee <glee@digitech.net.au>
Date: Wednesday, July 28, 1999 6:24 PM
Subject: Re: Quick question please
)ear Gabriel,
The problem that you face with this sort of protocol is
hat the second primary antibody can be bound by free valencies of the
iecondary antibody used in the initial indirect labelling procedure -
e. by the donkey anti-mouse. You are attempting to block this by the
rse of 185 antibody, but this will not be at a concentration that will
¡e effective. You should block by incubation with 50o/o rìorÍìal mouse serum
lnd then perform the final incubation with the HIS/RT7.2 conjugate
Jiluted in 50% normal mouse serum. That way, you ensure that the donkey
rnti-mouse is kept blocked throughout by normal mouse lgG.
3ood luck,
3raham
' Gabriel Lee wrote:
> Dear Graham
> Just a quick question if you don't mind, please.
> I have managed to co-localise the RT7.2 and ED1 antigens on the same
> sections using immunoflurorescence as the last step of my project. lt
> appears to have worked well. I initially sought advieæ from the
> Leukemia research lab at IMVS.
> However there remains some doubt in my mind as to whether the
> methodology can be open to criticism. The difficulty with the 2
> primary antibodies is that they are of the same isotype and are both
> mouse anti rat.
> Hence I ended using the following incubation sequence of antibodies:
> (1) primary ED1(monoclonal) as a first step
> (2) secondary donkey anti mouse antibody conjugated to Texas Red
> (3) anti-giardia 185 to flood the sections




I I wonder Graham if you could kindly advise me as to whether you see
: any problems with this protocol. I know that there is a theoretical
¡ possibility that the Texas Red conjugated secondary may be dislodged
I to bind onto RT7.2 but thought this would be unlikely.
' Thank you again for your kind advice.
Kind regards
Gabriel
It2lu
